| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 9.60e-07 | 36 | 187 | 6 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 9.60e-07 | 36 | 187 | 6 | GO:0015662 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 1.50e-06 | 10 | 187 | 4 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 1.50e-06 | 10 | 187 | 4 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 2.34e-06 | 11 | 187 | 4 | GO:0008556 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.48e-05 | 62 | 187 | 6 | GO:0019829 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 2.75e-05 | 7 | 187 | 3 | GO:1990239 | |
| GeneOntologyMolecularFunction | ligase activity | 3.96e-05 | 174 | 187 | 9 | GO:0016874 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 ATP7B HSPA13 UBA1 ACSS3 MRE11 ABCC1 DNAH10 ATP13A1 NTPCR ATP10D SMARCA2 SMARCA4 ATP1A1 ATP1A2 ATP1A3 ATP1A4 | 6.89e-05 | 614 | 187 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 7.52e-05 | 109 | 187 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | succinate-semialdehyde dehydrogenase (NAD+) activity | 8.72e-05 | 2 | 187 | 2 | GO:0004777 | |
| GeneOntologyMolecularFunction | succinate-semialdehyde dehydrogenase [NAD(P)+] activity | 8.72e-05 | 2 | 187 | 2 | GO:0009013 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 2.16e-04 | 13 | 187 | 3 | GO:0043047 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAGI1 DCDC1 MAP4 MAPT SPTAN1 SYNPO ADCY8 DST BRCA2 FLNA FLNB FLNC SHROOM3 GIT1 EPB41L4B KNSTRN CLIP3 CEP135 SNTG1 SNTG2 EML1 ATP1A1 EPB41L2 | 2.57e-04 | 1099 | 187 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 2.60e-04 | 3 | 187 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 2.72e-04 | 134 | 187 | 7 | GO:0003697 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX36 ATP7B HSPA13 ABCC1 DNAH10 ATP13A1 NTPCR ATP10D SMARCA4 ATP1A1 ATP1A2 ATP1A3 ATP1A4 | 2.76e-04 | 441 | 187 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | sequence-specific single stranded DNA binding | 3.38e-04 | 15 | 187 | 3 | GO:0098847 | |
| GeneOntologyMolecularFunction | acetate-CoA ligase activity | 5.17e-04 | 4 | 187 | 2 | GO:0003987 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 5.75e-04 | 41 | 187 | 4 | GO:0016877 | |
| GeneOntologyMolecularFunction | structural molecule activity | EPPK1 CLTCL1 MAP4 SPTAN1 DST AHNAK FGA COL6A3 FRAS1 GIT1 EPB41L4B SEC31A SEC31B HAPLN1 MRPL39 SNTG1 SNTG2 TNXB EPB41L2 | 7.24e-04 | 891 | 187 | 19 | GO:0005198 |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 8.19e-04 | 20 | 187 | 3 | GO:0046624 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 8.56e-04 | 5 | 187 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 8.56e-04 | 5 | 187 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DHX36 ATP7B RAB42 HSPA13 EFTUD2 GSPT2 EEFSEC ABCC1 DNAH10 ATP13A1 NTPCR ATP10D SMARCA4 ATP1A1 ATP1A2 ATP1A3 ATP1A4 | 1.02e-03 | 775 | 187 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 1.09e-03 | 22 | 187 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | selenocysteine insertion sequence binding | 1.28e-03 | 6 | 187 | 2 | GO:0035368 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | POLR3H JAK1 STK3 PNPT1 MYLK3 PIP5K1A PIPSL MOK GNPTAB MAP3K14 MAGI3 ACVR1C CERT1 POLR3A MTOR PRKCD CARD11 WEE2 IPMK | 1.32e-03 | 938 | 187 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | cyclase activity | 1.42e-03 | 24 | 187 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.47e-03 | 178 | 187 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.79e-03 | 26 | 187 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | actin binding | MAPT SPTAN1 SYNPO ADCY8 DST FLNA FLNB FLNC SHROOM3 SNTG1 SNTG2 EPB41L2 | 1.92e-03 | 479 | 187 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | magnesium ion binding | 2.34e-03 | 247 | 187 | 8 | GO:0000287 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DHX36 ATP7B RAB42 HSPA13 EFTUD2 GSPT2 EEFSEC ABCC1 DNAH10 ATP13A1 NTPCR ATP10D SMARCA4 ATP1A1 ATP1A2 ATP1A3 ATP1A4 | 2.36e-03 | 839 | 187 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DHX36 ATP7B RAB42 HSPA13 EFTUD2 GSPT2 EEFSEC ABCC1 DNAH10 ATP13A1 NTPCR ATP10D SMARCA4 ATP1A1 ATP1A2 ATP1A3 ATP1A4 | 2.39e-03 | 840 | 187 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DHX36 ATP7B RAB42 HSPA13 EFTUD2 GSPT2 EEFSEC ABCC1 DNAH10 ATP13A1 NTPCR ATP10D SMARCA4 ATP1A1 ATP1A2 ATP1A3 ATP1A4 | 2.39e-03 | 840 | 187 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 2.47e-03 | 29 | 187 | 3 | GO:0005540 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 2.23e-06 | 11 | 191 | 4 | GO:0010248 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | DHX36 CCP110 HIF1A MAP4 MAPT PARK7 SPTAN1 UBQLN4 SYNPO HNRNPA1 STN1 CDCA2 CEP120 MYLK3 CASKIN1 MKI67 PLXNB1 MRE11 FLNA GIT1 ARHGEF5 CEP192 CLIP3 RESF1 MTOR CEP135 SMARCA2 SMARCA4 PRKCD WEE2 | 6.26e-06 | 1342 | 191 | 30 | GO:0033043 |
| GeneOntologyBiologicalProcess | response to glycoside | 7.71e-06 | 5 | 191 | 3 | GO:1903416 | |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 1.54e-05 | 17 | 191 | 4 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 1.54e-05 | 17 | 191 | 4 | GO:0036376 | |
| GeneOntologyBiologicalProcess | response to potassium ion | 3.77e-05 | 21 | 191 | 4 | GO:0035864 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | EPPK1 MAP4 MAPT PARK7 SPTAN1 SYNPO KLHL41 CEP120 MYLK3 LOXL3 FLNA FLNC SHROOM3 GIT1 ARHGEF5 SH3KBP1 CEP192 USP8 CLIP3 MTOR PRKCD TNXB | 8.09e-05 | 957 | 191 | 22 | GO:0097435 |
| GeneOntologyBiologicalProcess | positive regulation of supramolecular fiber organization | 9.16e-05 | 196 | 191 | 9 | GO:1902905 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | DHX36 CCP110 HIF1A MAPT PARK7 SYNPO HNRNPA1 CEP120 MYLK3 MRE11 FLNA GIT1 ARHGEF5 RESF1 MTOR CEP135 | 9.27e-05 | 574 | 191 | 16 | GO:0010638 |
| GeneOntologyBiologicalProcess | central nervous system development | HIF1A MAPT SPEF2 GIT2 STK3 CEP120 BRCA2 SECISBP2 LOXL3 ALDH5A1 ABCC1 FLNA GIT1 PLXDC1 ODAD2 MED1 HAPLN1 MTOR SMARCA4 SNTG2 EML1 ATP1A2 ATP1A3 JRKL VPS13B | 1.19e-04 | 1197 | 191 | 25 | GO:0007417 |
| GeneOntologyBiologicalProcess | response to metal ion | ATP7B MAPT PARK7 HNRNPA1L2 HNRNPA1 ADCY1 ADCY8 NFATC3 FGA SEC31A ASS1 ATP1A2 ATP1A3 | 1.38e-04 | 415 | 191 | 13 | GO:0010038 |
| GeneOntologyCellularComponent | anchoring junction | MAGI1 EPPK1 ATP7B PARK7 SPTAN1 ASH1L SYNPO GIT2 JAK1 UBA1 DST AHNAK PIP5K1A LRRC7 FLNA FLNB FLNC SHROOM3 GIT1 PLXDC1 EPB41L4B ARHGEF5 SH3KBP1 MAGI3 PDIA3 THY1 PRKCD ATP1A1 ATP1A2 EPB41L2 PDZD2 | 1.47e-09 | 976 | 192 | 31 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | MAGI1 EPPK1 ATP7B PARK7 SPTAN1 ASH1L SYNPO UBA1 DST AHNAK LRRC7 FLNA SHROOM3 PLXDC1 EPB41L4B SH3KBP1 MAGI3 PRKCD ATP1A1 ATP1A2 PDZD2 | 1.31e-07 | 591 | 192 | 21 | GO:0005911 |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 3.22e-06 | 12 | 192 | 4 | GO:0005890 | |
| GeneOntologyCellularComponent | apical junction complex | 1.59e-05 | 158 | 192 | 9 | GO:0043296 | |
| GeneOntologyCellularComponent | bicellular tight junction | 2.89e-05 | 131 | 192 | 8 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 4.42e-05 | 139 | 192 | 8 | GO:0070160 | |
| GeneOntologyCellularComponent | postsynapse | MAP4 MAPT SYT17 SPTAN1 SYNPO ADCY1 ADCY8 DIP2A DST CASKIN1 GLRB LRRTM4 LRRC7 ADGRL2 FLNA GIT1 USP8 THY1 MTOR PRKCD ATP1A1 ATP1A2 ATP1A3 | 6.36e-05 | 1018 | 192 | 23 | GO:0098794 |
| GeneOntologyCellularComponent | cell-substrate junction | EPPK1 GIT2 JAK1 DST AHNAK PIP5K1A FLNA FLNB FLNC GIT1 SH3KBP1 PDIA3 THY1 EPB41L2 | 6.38e-05 | 443 | 192 | 14 | GO:0030055 |
| GeneOntologyCellularComponent | sarcolemma | 6.79e-05 | 190 | 192 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | membrane raft | MAPT PARK7 ADCY1 ADCY8 AHNAK CLIP3 THY1 CARD11 ATP1A1 ATP1A2 ATP1A4 ENO1 | 1.38e-04 | 362 | 192 | 12 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | MAPT PARK7 ADCY1 ADCY8 AHNAK CLIP3 THY1 CARD11 ATP1A1 ATP1A2 ATP1A4 ENO1 | 1.45e-04 | 364 | 192 | 12 | GO:0098857 |
| GeneOntologyCellularComponent | focal adhesion | GIT2 JAK1 DST AHNAK PIP5K1A FLNA FLNB FLNC GIT1 SH3KBP1 PDIA3 THY1 EPB41L2 | 1.85e-04 | 431 | 192 | 13 | GO:0005925 |
| GeneOntologyCellularComponent | myofibril | 2.26e-04 | 273 | 192 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | calyx of Held | 3.23e-04 | 36 | 192 | 4 | GO:0044305 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.65e-04 | 290 | 192 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | proteasome complex | 3.78e-04 | 67 | 192 | 5 | GO:0000502 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A2M ITIH1 ITIH2 DST FGA SPARCL1 LOXL3 COL6A3 FRAS1 FREM3 ITIH5 HAPLN1 EYS TNXB | 4.06e-04 | 530 | 192 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 4.97e-04 | 4 | 192 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | syntrophin complex | 4.97e-04 | 4 | 192 | 2 | GO:0016013 | |
| GeneOntologyCellularComponent | Z disc | 5.01e-04 | 151 | 192 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | 5.11e-04 | 249 | 192 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | I band | 8.78e-04 | 166 | 192 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | actin cytoskeleton | SPTAN1 SYNPO ADCY8 DST MYLK3 AHNAK LRRC7 FLNA FLNB FLNC SHROOM3 ARSJ ARHGEF5 EPB41L2 | 9.15e-04 | 576 | 192 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | myelin sheath | 9.17e-04 | 217 | 192 | 8 | GO:0043209 | |
| GeneOntologyCellularComponent | costamere | 1.03e-03 | 22 | 192 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 1.06e-03 | 49 | 192 | 4 | GO:0090533 | |
| GeneOntologyCellularComponent | extracellular matrix | A2M ITIH1 ITIH2 DST LRRTM4 FGA SPARCL1 LOXL3 COL6A3 FRAS1 FREM3 ITIH5 HAPLN1 EYS TNXB | 1.12e-03 | 656 | 192 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A2M ITIH1 ITIH2 DST LRRTM4 FGA SPARCL1 LOXL3 COL6A3 FRAS1 FREM3 ITIH5 HAPLN1 EYS TNXB | 1.15e-03 | 658 | 192 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 1.23e-03 | 6 | 192 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | axon | DHX36 HIF1A MAP4 MAPT PARK7 SPTAN1 SYNPO GIT2 ADCY8 DST LRRC7 FLNA GIT1 THY1 UNC13C ATP1A1 ATP1A3 ENO1 | 1.49e-03 | 891 | 192 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | glycoprotein complex | 1.51e-03 | 25 | 192 | 3 | GO:0090665 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 1.63e-03 | 55 | 192 | 4 | GO:0098533 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.76e-03 | 94 | 192 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | HIF1A ARID4B POLR3H UBQLN4 HNRNPA1L2 KMT2E HNRNPA1 STN1 EFTUD2 KMT2C BRCA2 SUPT5H PIP5K1A MGA MRE11 FLNA EXOSC3 MED1 POLR3A PRPF3 SMARCA2 SMARCA4 WDR82 EPB41L2 | 1.89e-03 | 1377 | 192 | 24 | GO:0140513 |
| GeneOntologyCellularComponent | microtubule plus-end | 2.11e-03 | 28 | 192 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | cell cortex | 2.35e-03 | 371 | 192 | 10 | GO:0005938 | |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP4 MAPT SYNPO ADCY1 ADCY8 DST GLRB LRRTM4 LRRC7 GIT1 USP8 ATP1A1 | 2.46e-03 | 503 | 192 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | endopeptidase complex | 2.52e-03 | 102 | 192 | 5 | GO:1905369 | |
| GeneOntologyCellularComponent | spectrin | 2.90e-03 | 9 | 192 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | postsynaptic density | MAP4 MAPT SYNPO ADCY1 ADCY8 DST LRRTM4 LRRC7 GIT1 USP8 ATP1A1 | 3.12e-03 | 451 | 192 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP4 MAPT SYNPO ADCY1 ADCY8 DST LRRTM4 LRRC7 GIT1 USP8 ATP1A1 ATP1A3 | 3.36e-03 | 523 | 192 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | intercalated disc | 3.55e-03 | 68 | 192 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | bBAF complex | 3.60e-03 | 10 | 192 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SYT17 SPTAN1 SYNPO ADCY1 ADCY8 DIP2A CASKIN1 LRRTM4 LRRC7 SPARCL1 ADGRL2 FLNA GIT1 USP8 THY1 MTOR | 3.67e-03 | 817 | 192 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | euchromatin | 4.36e-03 | 72 | 192 | 4 | GO:0000791 | |
| GeneOntologyCellularComponent | hemidesmosome | 4.37e-03 | 11 | 192 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | asymmetric synapse | MAP4 MAPT SYNPO ADCY1 ADCY8 DST LRRTM4 LRRC7 GIT1 USP8 ATP1A1 | 4.74e-03 | 477 | 192 | 11 | GO:0032279 |
| Domain | - | 2.46e-08 | 32 | 187 | 7 | 3.40.1110.10 | |
| Domain | - | 2.46e-08 | 32 | 187 | 7 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 4.78e-08 | 35 | 187 | 7 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 5.89e-08 | 36 | 187 | 7 | IPR018303 | |
| Domain | P_typ_ATPase | 5.89e-08 | 36 | 187 | 7 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.89e-08 | 36 | 187 | 7 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 7.20e-08 | 37 | 187 | 7 | IPR008250 | |
| Domain | E1-E2_ATPase | 7.20e-08 | 37 | 187 | 7 | PF00122 | |
| Domain | P-type_ATPase_IIC | 1.44e-07 | 6 | 187 | 4 | IPR005775 | |
| Domain | PDZ | MAGI1 PSMD9 AHNAK LRRC7 SHROOM3 MAGI3 SNTG1 SNTG2 CARD11 AHNAK2 PDZD2 | 2.93e-07 | 148 | 187 | 11 | SM00228 |
| Domain | - | MAGI1 PSMD9 AHNAK LRRC7 SHROOM3 MAGI3 SNTG1 SNTG2 CARD11 AHNAK2 PDZD2 | 3.36e-07 | 150 | 187 | 11 | 2.30.42.10 |
| Domain | PDZ | MAGI1 PSMD9 AHNAK LRRC7 SHROOM3 MAGI3 SNTG1 SNTG2 CARD11 AHNAK2 PDZD2 | 3.59e-07 | 151 | 187 | 11 | PS50106 |
| Domain | PDZ | MAGI1 PSMD9 AHNAK LRRC7 SHROOM3 MAGI3 SNTG1 SNTG2 CARD11 AHNAK2 PDZD2 | 3.84e-07 | 152 | 187 | 11 | IPR001478 |
| Domain | PDZ | MAGI1 PSMD9 AHNAK LRRC7 SHROOM3 MAGI3 SNTG1 SNTG2 AHNAK2 PDZD2 | 1.58e-06 | 141 | 187 | 10 | PF00595 |
| Domain | HAD-like_dom | 1.42e-05 | 79 | 187 | 7 | IPR023214 | |
| Domain | ATPase_P-typ_TM_dom | 1.61e-05 | 16 | 187 | 4 | IPR023298 | |
| Domain | - | 1.61e-05 | 16 | 187 | 4 | 1.20.1110.10 | |
| Domain | ITI_HC_C | 1.93e-05 | 6 | 187 | 3 | IPR010600 | |
| Domain | ITI_HC_C | 1.93e-05 | 6 | 187 | 3 | PF06668 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.09e-05 | 17 | 187 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.09e-05 | 17 | 187 | 4 | PF00689 | |
| Domain | Cation_ATPase_N | 2.67e-05 | 18 | 187 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 2.67e-05 | 18 | 187 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.35e-05 | 19 | 187 | 4 | IPR004014 | |
| Domain | VIT | 5.33e-05 | 8 | 187 | 3 | PF08487 | |
| Domain | VIT | 5.33e-05 | 8 | 187 | 3 | SM00609 | |
| Domain | ACTININ_2 | 7.42e-05 | 23 | 187 | 4 | PS00020 | |
| Domain | ACTININ_1 | 7.42e-05 | 23 | 187 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.42e-05 | 23 | 187 | 4 | IPR001589 | |
| Domain | CH | 9.07e-05 | 73 | 187 | 6 | PS50021 | |
| Domain | GIT | 9.97e-05 | 2 | 187 | 2 | SM00555 | |
| Domain | Gln-Leu-Gln_QLQ | 9.97e-05 | 2 | 187 | 2 | IPR014978 | |
| Domain | GIT1_C | 9.97e-05 | 2 | 187 | 2 | PF12205 | |
| Domain | GIT1/2_CC | 9.97e-05 | 2 | 187 | 2 | IPR032352 | |
| Domain | Caskin_C | 9.97e-05 | 2 | 187 | 2 | IPR032117 | |
| Domain | SnAC | 9.97e-05 | 2 | 187 | 2 | PF14619 | |
| Domain | QLQ | 9.97e-05 | 2 | 187 | 2 | SM00951 | |
| Domain | ARHGEF5_35 | 9.97e-05 | 2 | 187 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 9.97e-05 | 2 | 187 | 2 | IPR029212 | |
| Domain | QLQ | 9.97e-05 | 2 | 187 | 2 | PS51666 | |
| Domain | GIT_SHD | 9.97e-05 | 2 | 187 | 2 | PF08518 | |
| Domain | PP1_bind | 9.97e-05 | 2 | 187 | 2 | PF15276 | |
| Domain | GIT_CC | 9.97e-05 | 2 | 187 | 2 | PF16559 | |
| Domain | SnAC | 9.97e-05 | 2 | 187 | 2 | SM01314 | |
| Domain | GIT1_C | 9.97e-05 | 2 | 187 | 2 | IPR022018 | |
| Domain | GIT_SHD | 9.97e-05 | 2 | 187 | 2 | IPR013724 | |
| Domain | SnAC | 9.97e-05 | 2 | 187 | 2 | IPR029295 | |
| Domain | PP1-bd | 9.97e-05 | 2 | 187 | 2 | IPR029334 | |
| Domain | Caskin-tail | 9.97e-05 | 2 | 187 | 2 | PF16632 | |
| Domain | QLQ | 9.97e-05 | 2 | 187 | 2 | PF08880 | |
| Domain | CH-domain | 1.06e-04 | 75 | 187 | 6 | IPR001715 | |
| Domain | IG_FLMN | 1.13e-04 | 10 | 187 | 3 | SM00557 | |
| Domain | VIT | 1.13e-04 | 10 | 187 | 3 | PS51468 | |
| Domain | VIT | 1.13e-04 | 10 | 187 | 3 | IPR013694 | |
| Domain | Filamin | 1.54e-04 | 11 | 187 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.54e-04 | 11 | 187 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.54e-04 | 11 | 187 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.54e-04 | 11 | 187 | 3 | IPR017868 | |
| Domain | G_TR_1 | 2.62e-04 | 13 | 187 | 3 | PS00301 | |
| Domain | HnRNPA1 | 2.97e-04 | 3 | 187 | 2 | IPR021662 | |
| Domain | TAU_MAP_2 | 2.97e-04 | 3 | 187 | 2 | PS51491 | |
| Domain | Tubulin-binding | 2.97e-04 | 3 | 187 | 2 | PF00418 | |
| Domain | MAP_tubulin-bd_rpt | 2.97e-04 | 3 | 187 | 2 | IPR001084 | |
| Domain | HnRNPA1 | 2.97e-04 | 3 | 187 | 2 | PF11627 | |
| Domain | TAU_MAP_1 | 2.97e-04 | 3 | 187 | 2 | PS00229 | |
| Domain | MAP2/MAP4/Tau | 2.97e-04 | 3 | 187 | 2 | IPR027324 | |
| Domain | HSA | 5.90e-04 | 4 | 187 | 2 | SM00573 | |
| Domain | HSA | 5.90e-04 | 4 | 187 | 2 | PS51204 | |
| Domain | HSA_dom | 5.90e-04 | 4 | 187 | 2 | IPR014012 | |
| Domain | HSA | 5.90e-04 | 4 | 187 | 2 | PF07529 | |
| Domain | Ig_E-set | 6.26e-04 | 104 | 187 | 6 | IPR014756 | |
| Domain | CH | 6.82e-04 | 70 | 187 | 5 | PF00307 | |
| Domain | EFTu-like_2 | 7.21e-04 | 18 | 187 | 3 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 7.21e-04 | 18 | 187 | 3 | PF03144 | |
| Domain | G_TR_2 | 7.21e-04 | 18 | 187 | 3 | PS51722 | |
| Domain | - | 7.28e-04 | 71 | 187 | 5 | 1.10.418.10 | |
| Domain | TF_GTP-bd_dom | 8.50e-04 | 19 | 187 | 3 | IPR000795 | |
| Domain | - | 8.79e-04 | 74 | 187 | 5 | 3.40.50.410 | |
| Domain | Syntrophin | 9.78e-04 | 5 | 187 | 2 | IPR015482 | |
| Domain | DMAP_binding | 9.78e-04 | 5 | 187 | 2 | PF06464 | |
| Domain | VWFA | 1.40e-03 | 82 | 187 | 5 | PS50234 | |
| Domain | BRK | 1.46e-03 | 6 | 187 | 2 | SM00592 | |
| Domain | - | 1.46e-03 | 6 | 187 | 2 | 3.90.1290.10 | |
| Domain | DMAP1-bd | 1.46e-03 | 6 | 187 | 2 | IPR010506 | |
| Domain | BRK_domain | 1.46e-03 | 6 | 187 | 2 | IPR006576 | |
| Domain | Gasdermin | 1.46e-03 | 6 | 187 | 2 | PF04598 | |
| Domain | DMAP_binding | 1.46e-03 | 6 | 187 | 2 | SM01137 | |
| Domain | BRK | 1.46e-03 | 6 | 187 | 2 | PF07533 | |
| Domain | NA-bd_OB-fold | 1.47e-03 | 83 | 187 | 5 | IPR012340 | |
| Domain | GUANYLATE_KINASE_2 | 1.51e-03 | 23 | 187 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.51e-03 | 23 | 187 | 3 | PS00856 | |
| Domain | VWA | 1.55e-03 | 84 | 187 | 5 | SM00327 | |
| Domain | SH3_2 | 1.73e-03 | 86 | 187 | 5 | PF07653 | |
| Domain | SH3_2 | 1.73e-03 | 86 | 187 | 5 | IPR011511 | |
| Domain | Plectin | 2.03e-03 | 7 | 187 | 2 | PF00681 | |
| Domain | Notch_dom | 2.03e-03 | 7 | 187 | 2 | IPR000800 | |
| Domain | Plectin_repeat | 2.03e-03 | 7 | 187 | 2 | IPR001101 | |
| Domain | Notch | 2.03e-03 | 7 | 187 | 2 | PF00066 | |
| Domain | NL | 2.03e-03 | 7 | 187 | 2 | SM00004 | |
| Domain | PLEC | 2.03e-03 | 7 | 187 | 2 | SM00250 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.03e-06 | 55 | 153 | 7 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.59e-06 | 57 | 153 | 7 | MM15643 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 4.65e-05 | 37 | 153 | 5 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 4.65e-05 | 37 | 153 | 5 | MM15610 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 6.71e-05 | 93 | 153 | 7 | MM15204 | |
| Pathway | KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION | 1.01e-04 | 23 | 153 | 4 | M4361 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 1.06e-04 | 100 | 153 | 7 | M27467 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 1.94e-04 | 11 | 153 | 3 | M48099 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.16e-04 | 112 | 153 | 7 | MM15214 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX36 MAP4 RPN1 PARK7 SPTAN1 PSMD4 SUCLG2 HNRNPA1 PGD EFTUD2 CDCA2 UBA1 DST AHNAK MKI67 MGA MRE11 FLNA FLNB FLNC EXOSC3 FARSB SEC31A PDIA3 POLR3A PRPF3 MTHFD1 RTCA ASS1 SLTM SMARCA2 SMARCA4 GSDMA PRKCD WDR82 ENO1 EPB41L2 AHNAK2 | 1.53e-16 | 1353 | 194 | 38 | 29467282 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP4 MAPT SPTAN1 GIT2 HNRNPA1 STK3 UBA1 AHNAK MKI67 SECISBP2 PIP5K1A MGA EEFSEC MRE11 FLNA FLNC GIT1 EPB41L4B RBM33 EXOSC3 SEC31A LARP1B MED1 WDR82 ATP1A1 NNT AHNAK2 | 7.61e-15 | 724 | 194 | 27 | 36232890 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 CCP110 MAP4 MAPT SPTAN1 CDCA2 STK3 DST MYLK3 NFATC3 CASKIN2 AHNAK OSBPL6 SHROOM3 SASH1 GIT1 ARHGEF5 MAP3K14 MAGI3 CEP192 LARP1B USP8 RESF1 MTOR ASS1 EPB41L2 AHNAK2 | 4.65e-13 | 861 | 194 | 27 | 36931259 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | PARK7 HNRNPA1 EFTUD2 CDCA2 UBA1 BRCA2 SUPT5H MKI67 MGA MRE11 FLNA FARSB DIDO1 PRPF3 MTHFD1 GSDMA ATP1A1 ENO1 | 2.13e-12 | 357 | 194 | 18 | 37059091 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DHX36 EPPK1 MAP4 RPN1 PARK7 SPTAN1 PSMD9 HNRNPA1 EFTUD2 PNPT1 UBA1 GSPT2 AHNAK MRE11 FLNA FLNB GIT1 NTPCR EXOSC3 FARSB DIDO1 SEC31A PDIA3 MRPL39 USP8 PRPF3 MTHFD1 ASS1 SMARCA4 ATP1A1 ENO1 EPB41L2 AHNAK2 | 3.23e-12 | 1415 | 194 | 33 | 28515276 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M DHX36 EPPK1 MAP4 RPN1 SPTAN1 SYNPO HNRNPA1 ITIH2 EFTUD2 UBA1 DST AHNAK MKI67 MRE11 FLNA FLNB EXOSC3 FARSB DIDO1 MRPL39 PRPF3 MTHFD1 ASS1 SLTM SMARCA4 GSDMA ENO1 TBL2 EPB41L2 LRRFIP2 | 3.88e-12 | 1257 | 194 | 31 | 36526897 |
| Pubmed | DHX36 MAP4 RPN1 MAPT PARK7 SPTAN1 SYNPO HNRNPA1L2 HNRNPA1 DIP2A UBA1 DST CASKIN1 OSBPL6 FGA LRRC7 FLNA FLNB FLNC GIT1 EPB41L4B SH3KBP1 FARSB PDIA3 HAPLN1 THY1 MTHFD1 SMARCA4 ATP1A1 ATP1A2 ATP1A3 EPB41L2 LRRFIP2 | 4.36e-12 | 1431 | 194 | 33 | 37142655 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 MAP4 SPTAN1 HNRNPA1L2 EFTUD2 UBA1 SUPT5H AHNAK MRE11 FLNA FLNB FARSB DIDO1 MTHFD1 ASS1 SMARCA4 AHNAK2 | 7.00e-12 | 332 | 194 | 17 | 32786267 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX36 MAP4 RPN1 PARK7 SPTAN1 PSMD4 HNRNPA1 PGD EFTUD2 CDCA2 UBA1 SUPT5H MKI67 MRE11 FLNA FLNB DNAH10 ATP13A1 FARSB SEC31A PDIA3 POLR3A MTHFD1 MTOR SLTM SMARCA4 PRKCD ATP1A1 ENO1 NNT EPB41L2 LRRFIP2 | 1.91e-11 | 1425 | 194 | 32 | 30948266 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M EPPK1 MAP4 PSMD4 SYNPO SUCLG2 HNRNPA1 PGD EFTUD2 UBA1 SUPT5H AHNAK PIP5K1A ALDH5A1 MRE11 FLNA FLNB FLNC SEC31A PDIA3 MRPL39 MTOR RTCA SLTM SMARCA2 GSDMA ATP1A1 ENO1 NNT TBL2 AHNAK2 | 3.22e-11 | 1367 | 194 | 31 | 32687490 |
| Pubmed | DHX36 EPPK1 MAP4 SPTAN1 PNPT1 DST SUPT5H AHNAK MKI67 MRE11 FLNA FLNB FLNC DIDO1 MTOR SLTM SMARCA2 SMARCA4 ATP1A1 NNT EPB41L2 | 1.38e-10 | 653 | 194 | 21 | 22586326 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPPK1 CLTCL1 RPN1 PARK7 SPTAN1 ASH1L HNRNPA1 PGD EFTUD2 DST AHNAK FLNA FLNB FLNC PDIA3 EPG5 MTHFD1 SLTM EML1 ATP1A1 ENO1 NNT AHNAK2 | 1.86e-10 | 807 | 194 | 23 | 30575818 |
| Pubmed | MAGI1 PARK7 SPTAN1 SYNPO GIT2 ITIH1 EFTUD2 UBA1 DST NFATC3 CASKIN1 LRRC7 MGA SHROOM3 GIT1 SH3KBP1 FARSB DIDO1 SEC31A MTOR SMARCA4 EML1 ENO1 EPB41L2 LRRFIP2 | 2.00e-10 | 963 | 194 | 25 | 28671696 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | A2M EPPK1 RPN1 SPTAN1 HNRNPA1 EFTUD2 UBA1 DST AHNAK MRE11 FLNA FLNB FLNC SHROOM3 FARSB MTHFD1 ATP1A1 ENO1 | 2.45e-10 | 477 | 194 | 18 | 31300519 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | RPN1 MAPT SPTAN1 HNRNPA1L2 HNRNPA1 ITIH1 DST BRCA2 LRRC7 SASH1 ATP13A1 HAPLN1 THY1 MTHFD1 MTOR PRKCD ATP1A1 ATP1A4 ENO1 EPB41L2 | 3.80e-10 | 621 | 194 | 20 | 22794259 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | SPTAN1 PGD EFTUD2 JAK1 AHNAK FLNA FLNB ATP13A1 MTHFD1 ATP1A1 ENO1 TBL2 LRRFIP2 AHNAK2 | 4.09e-10 | 268 | 194 | 14 | 33024031 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP4 PARK7 PSMD4 HNRNPA1 EFTUD2 UBA1 DST AHNAK MKI67 MRE11 FLNA FARSB DIDO1 MED1 PDIA3 USP8 PRPF3 MTHFD1 SMARCA4 ELF2 ATP1A1 ENO1 EPB41L2 AHNAK2 | 5.81e-10 | 934 | 194 | 24 | 33916271 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | A2M EPPK1 CLTCL1 RPN1 PARK7 SPTAN1 PSMD4 SUCLG2 ITIH2 SORCS1 UBA1 AHNAK FLNB NTPCR PDIA3 MTHFD1 MTOR GSDMA ENO1 LRRFIP2 | 7.71e-10 | 647 | 194 | 20 | 26618866 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | EPPK1 MAP4 RPN1 SPTAN1 HNRNPA1 PGD UBA1 GSPT2 AHNAK FLNA FLNB PDIA3 MTHFD1 ASS1 ATP1A1 ENO1 TBL2 EPB41L2 LRRFIP2 | 8.08e-10 | 580 | 194 | 19 | 35676659 |
| Pubmed | A2M EPPK1 RPN1 SPTAN1 HNRNPA1 EFTUD2 BRCA2 AHNAK MKI67 FGA MRE11 FLNA FLNB DIDO1 PDIA3 PRPF3 SLTM GSDMA ENO1 NNT | 8.80e-10 | 652 | 194 | 20 | 31180492 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ARID4B MAP4 RPN1 HNRNPA1L2 HNRNPA1 EFTUD2 CDCA2 BRCA2 AHNAK MKI67 MGA MRE11 FLNA RBM33 NTPCR FARSB DIDO1 MED1 MTX2 PRPF3 SLTM SMARCA4 ELF2 ENO1 | 8.84e-10 | 954 | 194 | 24 | 36373674 |
| Pubmed | 9.39e-10 | 4 | 194 | 4 | 21849490 | ||
| Pubmed | HIF1A EPPK1 CLTCL1 RPN1 SPTAN1 HNRNPA1L2 HNRNPA1 EFTUD2 AHNAK MKI67 FLNA FLNB TBL2 | 1.45e-09 | 245 | 194 | 13 | 21182205 | |
| Pubmed | DHX36 CCP110 CLTCL1 MAP4 RPN1 PSMD4 HNRNPA1L2 HNRNPA1 EFTUD2 UBA1 PIP5K1A PIPSL MRE11 FLNA FARSB CEP192 LARP1B MED1 MRPL39 PRPF3 MTHFD1 ATP1A1 ATP1A2 ATP1A3 ATP1A4 ENO1 | 1.66e-09 | 1153 | 194 | 26 | 29845934 | |
| Pubmed | A2M EPPK1 SPTAN1 PGD SORCS1 PNPT1 BRCA2 MKI67 MGA ABCC1 FLNA SHROOM3 DIDO1 SEC31A PDIA3 USP8 CLIP3 PRPF3 SMARCA4 EML1 LRRFIP2 | 1.82e-09 | 754 | 194 | 21 | 35906200 | |
| Pubmed | MAGI1 DHX36 HIF1A MAP4 RPN1 PARK7 SPTAN1 PSMD4 HNRNPA1 EFTUD2 PNPT1 GSPT2 MKI67 MGA FLNA FARSB MED1 PDIA3 MTHFD1 ASS1 SMARCA2 WDR82 ATP1A1 ATP1A3 ENO1 TBL2 LRRFIP2 | 1.87e-09 | 1247 | 194 | 27 | 27684187 | |
| Pubmed | CLTCL1 RPN1 SPTAN1 PSMD4 IRF7 SYNPO SUCLG2 EFTUD2 DST AHNAK MKI67 ADGRL2 ABCC1 FLNA FLNB KNSTRN MAP3K14 EXOSC3 FARSB PDIA3 POLR3A MTX2 PRPF3 MTOR ATP1A1 ENO1 TBL2 LRRFIP2 AHNAK2 | 2.27e-09 | 1440 | 194 | 29 | 30833792 | |
| Pubmed | MAP4 SPTAN1 PSMD4 HNRNPA1 PGD EFTUD2 JAK1 UBA1 MGA MRE11 FLNA FLNB FLNC FARSB PDIA3 MTHFD1 WDR82 ENO1 | 2.40e-09 | 551 | 194 | 18 | 34728620 | |
| Pubmed | MAP4 HNRNPA1 KMT2C UBA1 MKI67 EEFSEC MRE11 FLNA RBM33 KNSTRN NTPCR ZNF507 FARSB DIDO1 MED1 PDIA3 THAP4 RESF1 PRPF3 MTHFD1 SMARCA2 SMARCA4 WDR82 ELF2 ATP1A1 | 3.17e-09 | 1103 | 194 | 25 | 34189442 | |
| Pubmed | EPPK1 PARK7 SYNPO UBA1 DST BRCA2 SUPT5H MKI67 ALDH5A1 ABCC1 FARSB SEC31A MRPL39 MTX2 SMARCA2 SMARCA4 ENO1 NNT TBL2 | 3.47e-09 | 634 | 194 | 19 | 34591612 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAGI1 MAP4 PARK7 SPTAN1 DST CASKIN2 AHNAK LRRC7 ADGRL2 MRE11 FLNA FLNB SHROOM3 EPB41L4B SH3KBP1 MAGI3 USP8 ENO1 | 3.56e-09 | 565 | 194 | 18 | 25468996 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HIF1A ARID4B RPN1 UBQLN4 HNRNPA1 EFTUD2 CDCA2 KMT2C DST SUPT5H AHNAK MKI67 MGA MRE11 ABCC1 TICRR EXOSC3 DIDO1 MED1 THAP4 PRPF3 SLTM SMARCA4 WDR82 ELF2 TBL2 JRKL | 4.09e-09 | 1294 | 194 | 27 | 30804502 |
| Pubmed | EPPK1 RPN1 PARK7 SPTAN1 PSMD9 STK11IP HNRNPA1 PGD HSPA13 JAK1 UBA1 DST AHNAK MKI67 PIP5K1A FLNA FLNB EXOSC3 FARSB DIDO1 SEC31A PDIA3 MTHFD1 ASS1 SLTM ATP1A1 EPB41L2 | 4.30e-09 | 1297 | 194 | 27 | 33545068 | |
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 4.67e-09 | 5 | 194 | 4 | 3035563 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | HNRNPA1L2 HNRNPA1 EFTUD2 AHNAK MKI67 MRE11 FLNA DIDO1 MED1 PRPF3 SMARCA4 WDR82 ATP1A4 | 4.91e-09 | 271 | 194 | 13 | 32433965 |
| Pubmed | DHX36 RPN1 PARK7 PSMD9 HNRNPA1L2 HNRNPA1 EFTUD2 STK3 UBA1 SUPT5H PIP5K1A PIPSL SLC25A48 MRE11 NTPCR EXOSC3 FARSB PDIA3 PARS2 POLR3A MRPL39 RESF1 MTHFD1 WDR82 ATP1A1 ENO1 TBL2 | 7.88e-09 | 1335 | 194 | 27 | 29229926 | |
| Pubmed | 1.19e-08 | 29 | 194 | 6 | 15071553 | ||
| Pubmed | 1.40e-08 | 6 | 194 | 4 | 3036582 | ||
| Pubmed | 1.47e-08 | 15 | 194 | 5 | 23782696 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 MAP4 HNRNPA1 EFTUD2 UBA1 DST SUPT5H AHNAK MKI67 MGA MRE11 FLNA FLNB FLNC PDIA3 PRPF3 MTHFD1 SLTM SMARCA4 ATP1A1 ENO1 NNT EPB41L2 | 1.68e-08 | 1024 | 194 | 23 | 24711643 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | A2M EFTUD2 DST MGA PAPPA2 MRE11 FLNA COL6A3 EPB41L4B RBM33 ZNF507 FARSB SLTM WDR82 | 1.98e-08 | 363 | 194 | 14 | 14691545 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPPK1 MAP4 RPN1 SPTAN1 HNRNPA1L2 HNRNPA1 EFTUD2 DST GSPT2 AHNAK MKI67 FLNA FLNB EPB41L4B PRPF3 MTHFD1 ASS1 SLTM SMARCA4 ATP1A1 ENO1 LRRFIP2 | 2.02e-08 | 949 | 194 | 22 | 36574265 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | A2M MAP4 SPTAN1 UBQLN4 PSMB10 HSPA13 EFTUD2 CDCA2 STK3 KMT2C UBA1 MKI67 MOK DYNC2I2 GIT1 KNSTRN SH3KBP1 MAP3K14 SEC31A THAP4 MTOR WDR82 UBXN2A CARD11 | 2.09e-08 | 1124 | 194 | 24 | 21900206 |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 2.14e-08 | 54 | 194 | 7 | 25631074 | |
| Pubmed | MAP4 SPTAN1 PSMD4 PGD EFTUD2 UBA1 AHNAK MKI67 CFAP47 FLNA FLNB FLNC SEC31A MTHFD1 SMARCA4 ENO1 | 2.17e-08 | 494 | 194 | 16 | 26831064 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | MAP4 RPN1 PARK7 SPTAN1 PSMD4 PGD EFTUD2 UBA1 ALDH5A1 FLNA FLNB SEC31A PDIA3 MRPL39 ATP1A1 ENO1 | 2.23e-08 | 495 | 194 | 16 | 28581483 |
| Pubmed | MAGI1 EPPK1 SYNPO ITIH1 CASKIN1 GLRB OSBPL6 LRRC7 DYNC2I2 GIT1 MAGI3 HAPLN1 CLIP3 MTX2 MTHFD1 | 2.30e-08 | 430 | 194 | 15 | 32581705 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | EPPK1 MAP4 SPTAN1 CDCA2 AHNAK MRE11 FLNA FLNB DIDO1 ATP1A1 EPB41L2 AHNAK2 | 2.51e-08 | 256 | 194 | 12 | 33397691 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | EPPK1 RPN1 PSMD4 FLNA NTPCR MTHFD1 ASS1 ATP1A2 ATP1A3 ATP1A4 ENO1 TBL2 | 2.51e-08 | 256 | 194 | 12 | 35777956 |
| Pubmed | MAP4 RPN1 AHNAK FLNA FLNC FARSB PDIA3 MTHFD1 MTOR GSDMA ATP1A1 ENO1 AHNAK2 | 2.61e-08 | 312 | 194 | 13 | 37120454 | |
| Pubmed | MAP4 RPN1 PARK7 SUCLG2 HNRNPA1 PGD EFTUD2 UBA1 AHNAK CASKIN1 MKI67 FLNA FLNB FARSB PDIA3 MTHFD1 SLTM SMARCA4 ATP1A1 ENO1 | 2.89e-08 | 803 | 194 | 20 | 36517590 | |
| Pubmed | HIF1A MAP4 SPTAN1 PSMD4 HNRNPA1 EFTUD2 MKI67 MGA FLNA NTPCR MED1 MTHFD1 SMARCA4 ATP1A1 ENO1 | 3.21e-08 | 441 | 194 | 15 | 31239290 | |
| Pubmed | Differential involvement of Na(+),K(+)-ATPase isozymes in preimplantation development of the mouse. | 3.24e-08 | 7 | 194 | 4 | 10837135 | |
| Pubmed | 3.24e-08 | 7 | 194 | 4 | 2158121 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MAP4 SYNPO UBA1 BRCA2 AHNAK MGA FLNA FLNC MED1 RESF1 PRPF3 SLTM ELF2 EPB41L2 AHNAK2 | 3.51e-08 | 444 | 194 | 15 | 34795231 |
| Pubmed | 3.99e-08 | 215 | 194 | 11 | 35973513 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DHX36 FBLL1 RPN1 PSMD4 HNRNPA1 EFTUD2 CDCA2 UBA1 SUPT5H AHNAK MKI67 FLNA FLNB FLNC EXOSC3 DIDO1 PDIA3 MTHFD1 SLTM SMARCA4 ATP1A1 ENO1 | 4.17e-08 | 989 | 194 | 22 | 36424410 |
| Pubmed | MAP4 ASH1L KMT2C MGA PLXNB1 MRE11 FLNA TICRR FLNB EPB41L4B ZNF507 FARSB DIDO1 CEP192 SEC31A WDFY4 RESF1 MTHFD1 AOPEP SLTM PRKCD VPS13B IPMK | 4.73e-08 | 1084 | 194 | 23 | 11544199 | |
| Pubmed | 5.06e-08 | 92 | 194 | 8 | 37343697 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | RPN1 POLR3H PARK7 PSMD4 SUCLG2 PGD EFTUD2 MRE11 FLNA FLNB FLNC MAGI3 CEP192 CERT1 POLR3A MRPL39 USP8 PRPF3 RTCA SMARCA2 UBXN2A TBL2 | 5.52e-08 | 1005 | 194 | 22 | 19615732 |
| Pubmed | A2M MAP4 RPN1 SPTAN1 SUCLG2 ITIH2 PNPT1 AHNAK MKI67 PIPSL EEFSEC MRE11 FLNA ATP13A1 KNSTRN FARSB DIDO1 LARP1B MED1 PDIA3 SMARCA4 WDR82 ATP1A1 ENO1 EPB41L2 LRRFIP2 | 5.52e-08 | 1371 | 194 | 26 | 36244648 | |
| Pubmed | SPTAN1 UBQLN4 ASH1L PSMD4 SYNPO HSPA13 JAK1 DIP2A DST OTOF SUPT5H HPF1 SPARCL1 ALDH5A1 FLNB GIT1 ATP13A1 GNPTAB MAGI3 SEC31A SEC31B THAP4 USP8 SMARCA4 ATP1A2 | 6.27e-08 | 1285 | 194 | 25 | 35914814 | |
| Pubmed | PARK7 SUCLG2 PNPT1 UBA1 PIP5K1A ALDH5A1 FLNA FLNB FARSB SEC31A PDIA3 MTHFD1 WDR82 ENO1 NNT EPB41L2 | 6.33e-08 | 534 | 194 | 16 | 35032548 | |
| Pubmed | UBQLN4 PSMD4 PSMD9 HNRNPA1 UBA1 SUPT5H AHNAK MKI67 MRE11 FLNC RBM33 SEC31A MED1 EPB41L2 | 6.40e-08 | 399 | 194 | 14 | 35987950 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CLTCL1 RPN1 SPTAN1 PSMD4 HNRNPA1L2 SUCLG2 HNRNPA1 EFTUD2 LRRC7 PIPSL MRE11 FLNA FLNB FLNC EXOSC3 POLR3A SMARCA2 SMARCA4 ENO1 EPB41L2 | 6.89e-08 | 847 | 194 | 20 | 35235311 |
| Pubmed | MAP4 SYNPO UBA1 FGA ALDH5A1 FLNA FLNC SH3KBP1 HAPLN1 ATP1A1 ATP1A2 ATP1A3 EPB41L2 | 7.37e-08 | 341 | 194 | 13 | 29791485 | |
| Pubmed | GIT2 JAK1 DST AHNAK PIP5K1A FLNA FLNB FLNC GIT1 PDIA3 THY1 EPB41L2 | 8.12e-08 | 285 | 194 | 12 | 21423176 | |
| Pubmed | MAP4 MAPT PARK7 SPTAN1 HNRNPA1L2 HNRNPA1 PGD UBA1 SEC31A PDIA3 THY1 ASS1 ATP1A1 ATP1A3 ENO1 EPB41L2 | 9.93e-08 | 552 | 194 | 16 | 36293380 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 PARK7 PSMD4 SUCLG2 MRE11 NTPCR EXOSC3 FARSB SEC31A POLR3A MTOR RTCA SMARCA2 SMARCA4 WDR82 ATP1A1 ATP1A2 EPB41L2 | 1.00e-07 | 704 | 194 | 18 | 29955894 |
| Pubmed | MAGI1 MAP4 RPN1 HNRNPA1 UBA1 DST AHNAK LRRC7 ADGRL2 MRE11 FLNB FARSB MAGI3 SEC31A MTHFD1 ATP1A1 ENO1 EPB41L2 | 1.09e-07 | 708 | 194 | 18 | 39231216 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPPK1 MAP4 PARK7 SPTAN1 PSMD9 HNRNPA1 PGD EFTUD2 UBA1 DST AHNAK MRE11 FLNA FLNB FLNC EXOSC3 FARSB SEC31A PDIA3 MTHFD1 ATP1A1 ENO1 EPB41L2 | 1.34e-07 | 1149 | 194 | 23 | 35446349 |
| Pubmed | SPTAN1 PSMD4 UBA1 DST GSPT2 AHNAK FLNA FLNB FLNC DIDO1 PRPF3 GSDMD AHNAK2 | 1.38e-07 | 360 | 194 | 13 | 33111431 | |
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 12393796 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 11153914 | ||
| Pubmed | Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes. | 1.71e-07 | 3 | 194 | 3 | 30819023 | |
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 19058785 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 8203495 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 25994790 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 2822726 | ||
| Pubmed | Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase. | 1.71e-07 | 3 | 194 | 3 | 26373354 | |
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 17947306 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 28465228 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 18044013 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 11252955 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 26911348 | ||
| Pubmed | 2.17e-07 | 153 | 194 | 9 | 27462432 | ||
| Pubmed | 2.17e-07 | 46 | 194 | 6 | 33403043 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | DHX36 RPN1 SPTAN1 PSMD4 JAK1 UBA1 MGA ALDH5A1 FLNA ATP1A1 ENO1 | 2.33e-07 | 256 | 194 | 11 | 32698014 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 HIF1A MAP4 MAPT ASH1L SYNPO ADCY1 KMT2C KIAA1328 PIP5K1A LRRC7 FLNB SHROOM3 EPB41L4B EXOSC3 MAGI3 CEP192 CERT1 THAP4 PRPF3 AOPEP ASS1 SMARCA2 SNTG2 VPS13B PDZD2 | 2.73e-07 | 1489 | 194 | 26 | 28611215 |
| Pubmed | Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. | 3.61e-07 | 50 | 194 | 6 | 24769233 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EPPK1 SPTAN1 UBQLN4 UBA1 AHNAK PIP5K1A MRE11 DIDO1 MED1 PRPF3 WDR82 ATP1A1 EPB41L2 | 3.85e-07 | 394 | 194 | 13 | 27248496 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ARID4B MAP4 MAPT SPTAN1 EFTUD2 UBA1 MKI67 MRE11 FLNA GIT1 ZNF507 DIDO1 MED1 SMARCA2 SMARCA4 PRKCD ELF2 EPB41L2 | 4.02e-07 | 774 | 194 | 18 | 15302935 |
| Pubmed | MAP4 SPTAN1 PSMD4 EFTUD2 UBA1 MRE11 FLNA FLNB FLNC MTHFD1 WDR82 EPB41L2 | 4.45e-07 | 334 | 194 | 12 | 30425250 | |
| Pubmed | MAGI1 DHX36 MAP4 SPTAN1 HNRNPA1 EFTUD2 FLNA FLNB LARP1B PRPF3 SMARCA4 | 4.58e-07 | 274 | 194 | 11 | 34244482 | |
| Pubmed | MAP4 RPN1 MAPT PARK7 SPTAN1 PSMD4 SYNPO UBA1 GSPT2 CASKIN1 LRRC7 SPARCL1 ALDH5A1 FLNA FLNB GIT1 ATP13A1 SH3KBP1 MTHFD1 ATP1A2 ENO1 EPB41L2 | 4.66e-07 | 1139 | 194 | 22 | 36417873 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | MAP4 RPN1 PSMD4 HNRNPA1L2 GIT2 HNRNPA1 UBA1 EEFSEC RBM33 FARSB MED1 PDIA3 RTCA SLTM ENO1 TBL2 LRRFIP2 | 4.82e-07 | 701 | 194 | 17 | 30196744 |
| Pubmed | MAGI1 ARID4B RPN1 PSMD4 FLNA FLNB SHROOM3 DNAH10 PLXDC1 MAP3K14 ENO1 | 5.10e-07 | 277 | 194 | 11 | 30745168 | |
| Pubmed | DHX36 MAP4 SPTAN1 HNRNPA1 EFTUD2 AHNAK MRE11 FLNA NTPCR DIDO1 MTHFD1 WDR82 | 5.38e-07 | 340 | 194 | 12 | 24332808 | |
| Pubmed | RPN1 PARK7 PSMD4 SUCLG2 PGD UBA1 ABCC1 FLNA FLNB SHROOM3 SEC31A PDIA3 MTHFD1 ATP1A1 ATP1A2 ATP1A3 ENO1 NNT EPB41L2 | 5.58e-07 | 878 | 194 | 19 | 37223481 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HNRNPA1L2 STN1 EFTUD2 STK3 UBA1 CEP120 AHNAK MKI67 FGA DYNC2I2 KNSTRN SH3KBP1 CEP192 PDIA3 PRPF3 ASS1 CEP135 SMARCA2 SMARCA4 WDR82 VPS13B LRRFIP2 | 5.88e-07 | 1155 | 194 | 22 | 20360068 |
| Interaction | BRCA1 interactions | HIF1A MAP4 MAPT PARK7 SPTAN1 PSMD4 PSMD9 HNRNPA1 PGD STN1 EFTUD2 CDCA2 JAK1 UBA1 DST BRCA2 SUPT5H AHNAK MKI67 ALDH5A1 CFAP47 MRE11 ABCC1 FLNA FLNB FLNC ERO1B MAP3K14 FARSB SEC31A ITIH5 MRPL39 PRPF3 MTHFD1 MTOR SMARCA2 SMARCA4 ENO1 | 1.08e-10 | 1249 | 190 | 38 | int:BRCA1 |
| Interaction | SUMO2 interactions | EPPK1 MAP4 PARK7 SPTAN1 IRF7 HNRNPA1L2 PGD EFTUD2 UBA1 DST SUPT5H AHNAK MKI67 MRE11 FLNA FLNB FARSB DIDO1 PDIA3 MTHFD1 ASS1 SMARCA4 ENO1 AHNAK2 | 1.89e-09 | 591 | 190 | 24 | int:SUMO2 |
| Interaction | YWHAH interactions | MAGI1 CCP110 EPPK1 MAPT SPTAN1 GIT2 EFTUD2 CDCA2 STK3 UBA1 DST NFATC3 CASKIN2 AHNAK OSBPL6 TICRR SHROOM3 SASH1 GIT1 ARHGEF5 MAGI3 CEP192 LARP1B MED1 USP8 RESF1 MTOR ASS1 CEP135 EPB41L2 AHNAK2 | 4.46e-08 | 1102 | 190 | 31 | int:YWHAH |
| Interaction | ISG15 interactions | HIF1A EPPK1 MAP4 PARK7 SPTAN1 PSMD4 PGD EFTUD2 JAK1 UBA1 AHNAK FLNA FLNB ATP13A1 MTHFD1 ATP1A1 ENO1 TBL2 LRRFIP2 AHNAK2 | 4.89e-08 | 494 | 190 | 20 | int:ISG15 |
| Interaction | ITGB3 interactions | SPTAN1 UBA1 SUPT5H FGA FLNA FLNB FLNC USP8 THY1 MTHFD1 ATP1A1 NNT | 7.78e-08 | 170 | 190 | 12 | int:ITGB3 |
| Interaction | CDK2 interactions | CCP110 HIF1A MAPT POLR3H SPTAN1 SYNPO PSMD9 KMT2E HNRNPA1 PGD EFTUD2 UBA1 DST BRCA2 AHNAK MRE11 FLNA FLNB FLNC SHROOM3 PDIA3 MTHFD1 ATP1A1 ENO1 LRRFIP2 | 9.90e-08 | 783 | 190 | 25 | int:CDK2 |
| Interaction | SLX4 interactions | PARK7 HNRNPA1 EFTUD2 CDCA2 UBA1 BRCA2 SUPT5H MKI67 MGA MRE11 FLNA RBM33 FARSB DIDO1 RESF1 PRPF3 MTHFD1 SMARCA4 GSDMA ATP1A1 ENO1 | 1.16e-07 | 572 | 190 | 21 | int:SLX4 |
| Interaction | EFTUD2 interactions | DHX36 HIF1A MAP4 RPN1 PARK7 SPTAN1 IRF7 PSMD9 HNRNPA1 EFTUD2 PNPT1 UBA1 SUPT5H AHNAK EEFSEC MRE11 FLNA FLNB GIT1 NTPCR EXOSC3 FARSB DIDO1 PDIA3 MRPL39 USP8 PRPF3 MTHFD1 SMARCA2 SMARCA4 ATP1A1 ENO1 EPB41L2 AHNAK2 | 6.76e-07 | 1449 | 190 | 34 | int:EFTUD2 |
| Interaction | GJA1 interactions | A2M RPN1 SPTAN1 UBQLN4 PSMD4 DST CASKIN2 FGA PIP5K1A ADGRL2 ABCC1 FLNA FLNC EPB41L4B SEC31A USP8 SIDT2 ATP1A1 VPS13B EPB41L2 | 6.88e-07 | 583 | 190 | 20 | int:GJA1 |
| Interaction | BIRC3 interactions | DHX36 ZFAND2A MAP4 RPN1 PARK7 SPTAN1 PSMD4 HNRNPA1 PGD EFTUD2 CDCA2 UBA1 SUPT5H MKI67 MRE11 FLNA FLNB DNAH10 ATP13A1 FARSB SEC31A PDIA3 MTHFD1 MTOR SLTM SMARCA4 PRKCD WDR82 ATP1A1 ENO1 NNT EPB41L2 | 9.46e-07 | 1334 | 190 | 32 | int:BIRC3 |
| Interaction | H2BC4 interactions | A2M MAP4 HNRNPA1L2 SUCLG2 KMT2C GSPT2 HPF1 SHROOM3 DIDO1 PDIA3 SLTM SMARCA2 ATP1A3 | 1.14e-06 | 259 | 190 | 13 | int:H2BC4 |
| Interaction | CHMP4B interactions | EPPK1 CLTCL1 FBLL1 MAPT PARK7 SPTAN1 HNRNPA1L2 HNRNPA1 EFTUD2 JAK1 BRCA2 AHNAK MKI67 FLNA FLNB FLNC SH3KBP1 USP8 MTX2 ENO1 AHNAK2 PDZD2 | 1.50e-06 | 727 | 190 | 22 | int:CHMP4B |
| Interaction | SERBP1 interactions | DHX36 MAP4 RPN1 MAPT PARK7 SPTAN1 PSMD4 SUCLG2 PGD EFTUD2 PNPT1 UBA1 PIP5K1A ABCC1 FLNA FLNB SHROOM3 DIDO1 SEC31A LARP1B PDIA3 POLR3A MRPL39 PRPF3 MTHFD1 PRKCD ATP1A1 ATP1A2 ATP1A3 ENO1 NNT TBL2 EPB41L2 | 1.51e-06 | 1432 | 190 | 33 | int:SERBP1 |
| Interaction | PINK1 interactions | A2M EPPK1 RPN1 PARK7 SPTAN1 HNRNPA1 EFTUD2 UBA1 DST AHNAK MRE11 FLNA FLNB FLNC SHROOM3 FARSB MTHFD1 GSDMA ATP1A1 ENO1 AHNAK2 | 1.88e-06 | 679 | 190 | 21 | int:PINK1 |
| Interaction | CHMP4C interactions | CLTCL1 FBLL1 RPN1 MAPT SPTAN1 SYNPO PGD EFTUD2 AHNAK MKI67 FLNA FLNB FLNC SH3KBP1 SEC31A PDIA3 USP8 MTX2 ASS1 SLTM ENO1 | 2.26e-06 | 687 | 190 | 21 | int:CHMP4C |
| Interaction | HDAC6 interactions | HIF1A EPPK1 MAP4 RPN1 MAPT SPTAN1 HNRNPA1 PGD EFTUD2 UBA1 GSPT2 BRCA2 AHNAK MRE11 FLNA FLNB WDFY4 PDIA3 MTHFD1 ASS1 ATP1A1 ENO1 TBL2 EPB41L2 LRRFIP2 | 2.31e-06 | 929 | 190 | 25 | int:HDAC6 |
| Interaction | CFL2 interactions | 2.37e-06 | 122 | 190 | 9 | int:CFL2 | |
| Interaction | AGR2 interactions | MAGI1 EPPK1 CLTCL1 RPN1 PARK7 SPTAN1 UBQLN4 ASH1L HNRNPA1 PGD EFTUD2 DST AHNAK FLNA FLNB FLNC PDIA3 EPG5 MTHFD1 SLTM EML1 ATP1A1 ENO1 NNT AHNAK2 | 2.54e-06 | 934 | 190 | 25 | int:AGR2 |
| Interaction | RICTOR interactions | DHX36 HIF1A MAP4 RPN1 UBA1 AHNAK MGA FLNA FLNB FLNC GIT1 FARSB SEC31A PDIA3 POLR3A MTHFD1 MTOR GSDMA ATP1A1 ENO1 EPB41L2 AHNAK2 | 3.03e-06 | 759 | 190 | 22 | int:RICTOR |
| Interaction | ECT2 interactions | DHX36 EPPK1 CLTCL1 FBLL1 RPN1 PARK7 SPTAN1 PSMD4 SYNPO HNRNPA1L2 SUCLG2 HNRNPA1 EFTUD2 DST AHNAK MKI67 FLNA FLNB FLNC LARP1B MTX2 CEP135 AHNAK2 PDZD2 | 3.42e-06 | 887 | 190 | 24 | int:ECT2 |
| Interaction | MAP1B interactions | EPPK1 RPN1 MAPT PARK7 PSMD4 IRF7 STK3 MKI67 FLNA NTPCR PRPF3 MTHFD1 ASS1 ATP1A2 ATP1A3 ATP1A4 ENO1 TBL2 | 3.72e-06 | 539 | 190 | 18 | int:MAP1B |
| Interaction | HSP90AB1 interactions | HIF1A MAPT SPEF2 SPTAN1 PSMD4 HNRNPA1 EFTUD2 KMT2C UBA1 BRCA2 AHNAK FLNA MAP3K14 EXOSC3 MAGI3 SEC31A WDFY4 PDIA3 USP8 MTHFD1 MTOR GSDMD UNC13C ENO1 EPB41L2 | 4.12e-06 | 960 | 190 | 25 | int:HSP90AB1 |
| Interaction | SLC6A4 interactions | A2M MAGI1 EPPK1 SYNPO ITIH1 CASKIN1 GLRB OSBPL6 LRRC7 DYNC2I2 GIT1 MAGI3 HAPLN1 CLIP3 MTX2 MTHFD1 | 4.17e-06 | 437 | 190 | 16 | int:SLC6A4 |
| Interaction | OBSL1 interactions | EPPK1 RPN1 PSMB10 HNRNPA1 EFTUD2 UBA1 DST MYLK3 SUPT5H AHNAK MKI67 PIPSL MGA MRE11 FLNA FLNB FLNC SHROOM3 PDIA3 ARHGEF35 PRPF3 SLTM SMARCA4 ENO1 | 4.54e-06 | 902 | 190 | 24 | int:OBSL1 |
| Interaction | CIT interactions | MAGI1 DHX36 EPPK1 CLTCL1 FBLL1 RPN1 SPTAN1 ASH1L SYNPO HNRNPA1L2 HNRNPA1 EFTUD2 UBA1 SUPT5H AHNAK MKI67 SECISBP2 FLNA FLNB FLNC EXOSC3 MAGI3 DIDO1 SEC31A MED1 SEC31B MTX2 PRPF3 SMARCA2 SMARCA4 ATP1A1 AHNAK2 | 5.52e-06 | 1450 | 190 | 32 | int:CIT |
| Interaction | TRRAP interactions | A2M HIF1A EPPK1 SPTAN1 SORCS1 PNPT1 BRCA2 MKI67 MGA MRE11 ABCC1 SHROOM3 DIDO1 MED1 PDIA3 USP8 CLIP3 PRPF3 SMARCA4 ELF2 EML1 LRRFIP2 | 5.74e-06 | 790 | 190 | 22 | int:TRRAP |
| Interaction | YWHAG interactions | MAGI1 CCP110 MAPT SPTAN1 SYNPO GIT2 PGD EFTUD2 CDCA2 STK3 UBA1 DST NFATC3 CASKIN2 OSBPL6 FLNA TICRR SHROOM3 SASH1 GIT1 ARHGEF5 MAGI3 CEP192 LARP1B USP8 MTOR PRKCD EPB41L2 AHNAK2 | 6.09e-06 | 1248 | 190 | 29 | int:YWHAG |
| Interaction | YWHAQ interactions | CCP110 EPPK1 MAP4 MAPT PARK7 UBQLN4 HNRNPA1 PGD EFTUD2 STK3 DST NFATC3 OSBPL6 FGA FLNA TICRR SHROOM3 SASH1 ARHGEF5 CEP192 LARP1B MED1 USP8 MTX2 MTOR ENO1 EPB41L2 | 6.61e-06 | 1118 | 190 | 27 | int:YWHAQ |
| Interaction | KCTD13 interactions | DHX36 MAP4 RPN1 MAPT PARK7 SPTAN1 SYNPO HNRNPA1 DIP2A UBA1 DST CASKIN1 OSBPL6 FGA LRRC7 FLNA FLNB FLNC GIT1 EPB41L4B SH3KBP1 FARSB PDIA3 HAPLN1 THY1 MTHFD1 SMARCA4 ATP1A1 ATP1A3 EPB41L2 LRRFIP2 | 6.79e-06 | 1394 | 190 | 31 | int:KCTD13 |
| Interaction | SIRT7 interactions | DHX36 EPPK1 MAP4 SPTAN1 PNPT1 DST SUPT5H AHNAK MKI67 MRE11 FLNA FLNB FLNC DIDO1 MTOR SLTM SMARCA2 SMARCA4 ATP1A1 NNT EPB41L2 | 7.74e-06 | 744 | 190 | 21 | int:SIRT7 |
| Interaction | CDK9 interactions | HIF1A MAP4 RPN1 SPTAN1 PSMD4 HNRNPA1 EFTUD2 BRCA2 SUPT5H FLNA FLNB MDFIC EXOSC3 SEC31A MED1 SLTM WDR82 ATP1A1 LRRFIP2 AHNAK2 | 7.89e-06 | 685 | 190 | 20 | int:CDK9 |
| Interaction | KCNA3 interactions | MAGI1 EPPK1 MAP4 RPN1 SPEF2 HNRNPA1 KMT2C UBA1 DST AHNAK LRRC7 ADGRL2 MRE11 FLNB FARSB MAGI3 SEC31A MTHFD1 SMARCA4 CARD11 ATP1A1 ENO1 EPB41L2 | 8.26e-06 | 871 | 190 | 23 | int:KCNA3 |
| Interaction | SMC5 interactions | ARID4B MAP4 RPN1 HNRNPA1L2 HNRNPA1 STN1 EFTUD2 CDCA2 BRCA2 AHNAK MKI67 MGA MRE11 FLNA RBM33 NTPCR FARSB DIDO1 MED1 MTX2 PRPF3 SLTM SMARCA4 ELF2 ENO1 | 8.35e-06 | 1000 | 190 | 25 | int:SMC5 |
| Interaction | PRKCZ interactions | MAPT PARK7 HNRNPA1 PGD JAK1 UBA1 FLNA FLNC EPB41L4B PDIA3 MRPL39 MTHFD1 MTOR PRKCD ATP1A1 | 8.99e-06 | 412 | 190 | 15 | int:PRKCZ |
| Interaction | PSMD14 interactions | MAGI1 ZFAND2A ARID4B RPN1 UBQLN4 PSMD4 PSMD9 UBA1 FLNA FLNB SHROOM3 DNAH10 PLXDC1 MAP3K14 MTOR ENO1 AHNAK2 | 1.10e-05 | 527 | 190 | 17 | int:PSMD14 |
| Interaction | PRNP interactions | MAGI1 MAP4 MAPT ASH1L PSMD4 SYNPO JAK1 KMT2C UBA1 CEP120 CASKIN2 FGA SPARCL1 MGA ALDH5A1 MRE11 FLNA FLNC SH3KBP1 SEC31A HAPLN1 THAP4 ATP1A1 ATP1A2 ATP1A3 ENO1 EPB41L2 | 1.25e-05 | 1158 | 190 | 27 | int:PRNP |
| Interaction | KLHL4 interactions | 1.35e-05 | 33 | 190 | 5 | int:KLHL4 | |
| Interaction | UBE2M interactions | MAP4 RPN1 MAPT POLR3H PARK7 SPTAN1 PSMD4 PGD EFTUD2 UBA1 ALDH5A1 FLNA FLNB SEC31A PDIA3 MRPL39 MTOR ATP1A1 ENO1 | 1.35e-05 | 651 | 190 | 19 | int:UBE2M |
| Interaction | LDHA interactions | HIF1A MAPT PARK7 SLC24A3 SUCLG2 HNRNPA1 PGD EFTUD2 SPATA31D1 DST MKI67 PDIA3 ASS1 ENO1 | 1.36e-05 | 375 | 190 | 14 | int:LDHA |
| Interaction | BAP1 interactions | HIF1A EPPK1 MAP4 PARK7 SPTAN1 PSMD4 PSMD9 HNRNPA1 PGD EFTUD2 KMT2C UBA1 DST BRCA2 AHNAK MRE11 FLNA FLNB FLNC EXOSC3 FARSB DIDO1 SEC31A PDIA3 MTHFD1 ELF2 ATP1A1 ENO1 EPB41L2 | 1.61e-05 | 1314 | 190 | 29 | int:BAP1 |
| Interaction | CEBPA interactions | HIF1A MAP4 RPN1 SPTAN1 HNRNPA1 KMT2C UBA1 MKI67 EEFSEC MRE11 FLNA RBM33 KNSTRN NTPCR ZNF507 FARSB DIDO1 MED1 PDIA3 THAP4 RESF1 PRPF3 MTHFD1 SMARCA2 SMARCA4 WDR82 ELF2 ATP1A1 | 1.64e-05 | 1245 | 190 | 28 | int:CEBPA |
| Interaction | USP14 interactions | MAP4 MAPT SPTAN1 UBQLN4 PSMD4 EFTUD2 UBA1 AHNAK MRE11 FLNA FLNB FLNC MTHFD1 WDR82 EPB41L2 AHNAK2 | 1.69e-05 | 489 | 190 | 16 | int:USP14 |
| Interaction | NAA40 interactions | MAP4 PARK7 PSMD4 HNRNPA1 EFTUD2 UBA1 DST AHNAK MKI67 MRE11 FLNA FARSB DIDO1 MED1 PDIA3 USP8 PRPF3 MTHFD1 SMARCA4 ELF2 ATP1A1 ENO1 EPB41L2 AHNAK2 | 1.74e-05 | 978 | 190 | 24 | int:NAA40 |
| Interaction | ASXL1 interactions | PARK7 HNRNPA1 EFTUD2 KMT2C BRCA2 FLNA NTPCR MTHFD1 ELF2 ATP1A1 ATP1A3 ENO1 | 1.83e-05 | 286 | 190 | 12 | int:ASXL1 |
| Interaction | ADGRB1 interactions | 2.10e-05 | 36 | 190 | 5 | int:ADGRB1 | |
| Interaction | PSMD3 interactions | ZFAND2A MAP4 MAPT UBQLN4 PSMD4 PSMD9 EFTUD2 BRCA2 FLNA FLNB FLNC POLR3A PRPF3 ATP1A1 | 2.11e-05 | 390 | 190 | 14 | int:PSMD3 |
| Interaction | HSP90AA1 interactions | A2M HIF1A MAPT SPTAN1 PSMD4 HNRNPA1 ITIH1 EFTUD2 JAK1 UBA1 MYLK3 BRCA2 SUPT5H FGA MRE11 FLNA COL6A3 MAP3K14 DIDO1 ACVR1C THAP4 MTHFD1 MTOR GSDMD PRKCD UNC13C ATP1A1 ENO1 | 2.12e-05 | 1263 | 190 | 28 | int:HSP90AA1 |
| Interaction | XRCC6 interactions | HIF1A MAP4 PSMD4 HNRNPA1 EFTUD2 CDCA2 UBA1 BRCA2 SUPT5H MKI67 MGA MRE11 RBM33 FARSB DIDO1 MED1 PDIA3 PARS2 PRPF3 MTHFD1 SMARCA4 ATP1A1 ENO1 | 2.27e-05 | 928 | 190 | 23 | int:XRCC6 |
| Interaction | RPA4 interactions | MAP4 RPN1 SPTAN1 PSMD4 HNRNPA1 PGD DST SUPT5H AHNAK MKI67 MRE11 FLNA MTOR SLTM EPB41L2 | 2.66e-05 | 452 | 190 | 15 | int:RPA4 |
| Interaction | PAGE4 interactions | DHX36 RPN1 SPTAN1 PSMD4 JAK1 UBA1 MGA ALDH5A1 FLNA ATP1A1 ENO1 | 2.96e-05 | 253 | 190 | 11 | int:PAGE4 |
| Interaction | TRIM37 interactions | HIF1A EPPK1 MAP4 RPN1 SPTAN1 HNRNPA1 AHNAK MKI67 MGA FLNB KNSTRN CEP192 PDIA3 MTOR CARD11 ENO1 NNT LRRFIP2 | 3.05e-05 | 630 | 190 | 18 | int:TRIM37 |
| Interaction | YWHAB interactions | MAGI1 CCP110 MAPT PARK7 SPTAN1 HNRNPA1 PGD EFTUD2 STK3 DST NFATC3 OSBPL6 TICRR SHROOM3 SASH1 ARHGEF5 GNPTAB CEP192 USP8 MTOR PRKCD ENO1 EPB41L2 AHNAK2 | 3.12e-05 | 1014 | 190 | 24 | int:YWHAB |
| Interaction | VCP interactions | HIF1A EPPK1 RPN1 MAPT PARK7 SPTAN1 PSMD4 PSMD9 SUCLG2 HNRNPA1 EFTUD2 STK3 UBA1 MKI67 ALDH5A1 MRE11 ABCC1 FLNB FARSB SEC31A PDIA3 MRPL39 MTOR SMARCA4 PRKCD WDR82 UBXN2A ATP1A1 ENO1 NNT | 3.16e-05 | 1435 | 190 | 30 | int:VCP |
| Interaction | HTT interactions | EPPK1 RPN1 MAPT SPTAN1 HNRNPA1 ITIH1 DST BRCA2 LRRC7 SASH1 GIT1 ATP13A1 HAPLN1 USP8 THY1 MTHFD1 MTOR PRKCD WDR82 ATP1A1 ATP1A4 ENO1 EPB41L2 | 3.21e-05 | 949 | 190 | 23 | int:HTT |
| Interaction | PPIA interactions | PARK7 SPEF2 PSMD4 HNRNPA1 PGD EFTUD2 DST SUPT5H AHNAK MKI67 OSBPL6 MRE11 FLNC EPB41L4B RBM33 DIDO1 SEC31A MED1 SEC31B PDIA3 SMARCA2 ENO1 | 3.48e-05 | 888 | 190 | 22 | int:PPIA |
| Interaction | PABPC1 interactions | MAP4 MAPT PARK7 PSMD9 HNRNPA1 EFTUD2 KMT2C UBA1 GSPT2 AHNAK SECISBP2 FLNA FLNB FLNC SH3KBP1 LARP1B WDFY4 PRPF3 ATP1A1 | 3.59e-05 | 699 | 190 | 19 | int:PABPC1 |
| Interaction | ATG16L1 interactions | CCP110 MAP4 RPN1 MAPT PSMD4 PSMD9 GIT2 STK11IP HNRNPA1 DIP2A UBA1 SECISBP2 LRRC7 EEFSEC FLNA SHROOM3 RBM33 FARSB CEP192 MED1 PDIA3 RTCA SLTM ENO1 TBL2 LRRFIP2 | 3.65e-05 | 1161 | 190 | 26 | int:ATG16L1 |
| Interaction | CXXC1 interactions | 3.66e-05 | 132 | 190 | 8 | int:CXXC1 | |
| Interaction | TRAF6 interactions | HIF1A EPPK1 MAPT PARK7 IRF7 KMT2E HNRNPA1 DYNC2I2 MAP3K14 MTHFD1 MTOR PRKCD CARD11 ENO1 IPMK | 3.68e-05 | 465 | 190 | 15 | int:TRAF6 |
| Interaction | CDH1 interactions | MAGI1 MAP4 PARK7 SPTAN1 DST CASKIN2 AHNAK MKI67 LRRC7 ADGRL2 MRE11 FLNA FLNB SHROOM3 EPB41L4B SH3KBP1 MAGI3 USP8 AOPEP ENO1 | 4.05e-05 | 768 | 190 | 20 | int:CDH1 |
| Interaction | CD274 interactions | RPN1 PARK7 UBQLN4 PGD JAK1 FLNB FARSB PDIA3 USP8 MTHFD1 MTOR GSDMA ATP1A1 | 5.06e-05 | 369 | 190 | 13 | int:CD274 |
| Interaction | HEXIM1 interactions | DHX36 CCP110 HIF1A CLTCL1 MAP4 RPN1 PSMD4 HNRNPA1L2 HNRNPA1 EFTUD2 UBA1 PIP5K1A FLNA FARSB MED1 MTHFD1 WDR82 ATP1A1 ATP1A2 ATP1A3 ATP1A4 ENO1 | 5.26e-05 | 913 | 190 | 22 | int:HEXIM1 |
| Interaction | PLOD2 interactions | 5.44e-05 | 180 | 190 | 9 | int:PLOD2 | |
| Interaction | RNF43 interactions | DHX36 PSMD4 HNRNPA1 STK3 CASKIN2 MKI67 SECISBP2 LRRC7 EPB41L4B RBM33 PDIA3 CEP135 VPS13B AHNAK2 | 5.66e-05 | 427 | 190 | 14 | int:RNF43 |
| Interaction | H2BC12 interactions | MAP4 MAPT HNRNPA1L2 SUCLG2 DST AHNAK SHROOM3 DIDO1 PDIA3 SLTM ATP1A3 ENO1 | 5.80e-05 | 322 | 190 | 12 | int:H2BC12 |
| Interaction | ATP1A2 interactions | 6.36e-05 | 45 | 190 | 5 | int:ATP1A2 | |
| Interaction | CEP120 interactions | 6.58e-05 | 106 | 190 | 7 | int:CEP120 | |
| Interaction | ASXL2 interactions | PARK7 HNRNPA1 EFTUD2 KMT2C UBA1 FLNA MTX2 MTHFD1 ELF2 ATP1A3 ENO1 | 6.73e-05 | 277 | 190 | 11 | int:ASXL2 |
| Interaction | GART interactions | 6.84e-05 | 230 | 190 | 10 | int:GART | |
| Interaction | HCN1 interactions | 7.41e-05 | 108 | 190 | 7 | int:HCN1 | |
| Interaction | DTX3 interactions | 7.41e-05 | 108 | 190 | 7 | int:DTX3 | |
| Interaction | LRRK2 interactions | HIF1A MAP4 MAPT PARK7 PSMD4 SUCLG2 STN1 STK3 BRCA2 AHNAK NTPCR DIDO1 PDIA3 MRPL39 ENO1 | 7.63e-05 | 496 | 190 | 15 | int:LRRK2 |
| Interaction | TNIP1 interactions | EPPK1 MAP4 RPN1 SPTAN1 HNRNPA1L2 GIT2 HNRNPA1 EFTUD2 DST GSPT2 AHNAK MKI67 FLNA FLNB EPB41L4B PRPF3 MTHFD1 ASS1 CEP135 SLTM SMARCA4 GSDMA CARD11 ATP1A1 ENO1 LRRFIP2 | 7.95e-05 | 1217 | 190 | 26 | int:TNIP1 |
| Interaction | PHLPP1 interactions | EPPK1 MAP4 SPTAN1 CDCA2 AHNAK MRE11 FLNA FLNB DIDO1 ATP1A1 EPB41L2 AHNAK2 | 7.98e-05 | 333 | 190 | 12 | int:PHLPP1 |
| Interaction | CDC73 interactions | CLTCL1 RPN1 PGD EFTUD2 KMT2C UBA1 SUPT5H FLNA FLNB FLNC MTHFD1 WDR82 ENO1 | 7.99e-05 | 386 | 190 | 13 | int:CDC73 |
| Interaction | AIMP2 interactions | MAP4 PARK7 PSMD4 HNRNPA1 EFTUD2 UBA1 FLNA FLNB FLNC PDIA3 MTHFD1 WDR82 ATP1A1 ENO1 | 8.99e-05 | 446 | 190 | 14 | int:AIMP2 |
| Interaction | H2AC4 interactions | EPPK1 MAPT PARK7 SPTAN1 UBQLN4 PSMD4 HNRNPA1 KMT2C SUPT5H PIP5K1A FLNC DNAH10 PRPF3 ATP1A1 EPB41L2 | 9.53e-05 | 506 | 190 | 15 | int:H2AC4 |
| Interaction | AMBP interactions | 9.73e-05 | 26 | 190 | 4 | int:AMBP | |
| Interaction | MYH9 interactions | SPEF2 SPTAN1 PSMB10 PSMD4 SYNPO HNRNPA1 EFTUD2 DST AHNAK PIP5K1A FLNA FLNB SHROOM3 WDFY4 ATP1A1 ENO1 NNT EPB41L2 LRRFIP2 | 9.82e-05 | 754 | 190 | 19 | int:MYH9 |
| Interaction | CTTN interactions | MAPT SPTAN1 SYNPO SUCLG2 GSPT2 BRCA2 AHNAK FLNA FLNB THY1 SMARCA4 WDR82 EPB41L2 LRRFIP2 | 9.88e-05 | 450 | 190 | 14 | int:CTTN |
| Interaction | MED4 interactions | A2M CCP110 POLR3H SPTAN1 GIT2 STN1 DST CEP120 AHNAK PIP5K1A FLNB GIT1 MED1 CEP135 | 9.88e-05 | 450 | 190 | 14 | int:MED4 |
| Interaction | H3C1 interactions | ARID4B MAPT SPTAN1 ASH1L HNRNPA1L2 HNRNPA1 ITIH2 EFTUD2 CDCA2 KMT2C AHNAK HPF1 MKI67 MGA DIDO1 PDIA3 PRPF3 SMARCA2 SMARCA4 ELF2 PDZD2 | 1.25e-04 | 901 | 190 | 21 | int:H3C1 |
| Interaction | H2BC3 interactions | EPPK1 SPTAN1 UBQLN4 PSMD4 KMT2C AHNAK PIP5K1A MRE11 DIDO1 MED1 PRPF3 WDR82 ATP1A1 | 1.32e-04 | 406 | 190 | 13 | int:H2BC3 |
| Interaction | PIPSL interactions | CCP110 ASH1L PSMD4 PIP5K1A PIPSL HS3ST2 MGA MOK CEP192 POLR3A | 1.45e-04 | 252 | 190 | 10 | int:PIPSL |
| Interaction | GAN interactions | DCDC1 SPTAN1 HNRNPA1 UBA1 DST EEFSEC COL6A3 DNAH10 MRPL39 MTHFD1 | 1.50e-04 | 253 | 190 | 10 | int:GAN |
| Interaction | U2AF2 interactions | MAP4 RPN1 MAPT PARK7 SPTAN1 HNRNPA1 EFTUD2 UBA1 AHNAK MKI67 MRE11 FLNA PDIA3 MTX2 PRPF3 MTHFD1 ATP1A1 | 1.52e-04 | 651 | 190 | 17 | int:U2AF2 |
| Interaction | FGD5 interactions | 1.58e-04 | 207 | 190 | 9 | int:FGD5 | |
| Interaction | APEX1 interactions | DHX36 ZFAND2A HIF1A CLTCL1 ARID4B MAPT PARK7 HNRNPA1 EFTUD2 CDCA2 DIP2A BRCA2 NFATC3 CASKIN2 SUPT5H AHNAK MGA ABCC1 GIT1 ATP13A1 DIDO1 SEC31A EPG5 SMARCA4 ELF2 EPB41L2 | 1.60e-04 | 1271 | 190 | 26 | int:APEX1 |
| Interaction | PPT1 interactions | RPN1 SPTAN1 HNRNPA1L2 HNRNPA1 AHNAK CFAP47 GIT1 PDIA3 ATP1A1 ENO1 | 1.65e-04 | 256 | 190 | 10 | int:PPT1 |
| Interaction | AAR2 interactions | EPPK1 MAP4 RPN1 PARK7 HNRNPA1 EFTUD2 UBA1 GSPT2 AHNAK FLNA FLNB FARSB PDIA3 MTHFD1 ASS1 ATP1A1 ENO1 | 1.69e-04 | 657 | 190 | 17 | int:AAR2 |
| Interaction | MAPK6 interactions | A2M MAP4 SPTAN1 PSMD4 DST BRCA2 FGA MOK DYNC2I2 KNSTRN NTPCR WDFY4 THAP4 ATP1A1 | 1.70e-04 | 474 | 190 | 14 | int:MAPK6 |
| Interaction | EMC1 interactions | RPN1 MAPT HSPA13 EFTUD2 SUPT5H AHNAK ATP13A1 MED1 ASS1 ATP1A1 ENO1 NNT AHNAK2 | 1.76e-04 | 418 | 190 | 13 | int:EMC1 |
| Interaction | C11orf52 interactions | MAGI1 SPTAN1 DIP2A DST CASKIN2 PIP5K1A ADGRL2 ABCC1 EPB41L4B ATP1A1 EPB41L2 | 1.86e-04 | 311 | 190 | 11 | int:C11orf52 |
| Interaction | TXNIP interactions | 1.89e-04 | 212 | 190 | 9 | int:TXNIP | |
| Interaction | PTEN interactions | PARK7 SPTAN1 PSMD4 SUCLG2 STK11IP HNRNPA1 EFTUD2 UBA1 MKI67 EEFSEC FLNA FLNB SHROOM3 FARSB MAGI3 USP8 MTHFD1 MTOR SMARCA4 EML1 NNT | 1.90e-04 | 929 | 190 | 21 | int:PTEN |
| Interaction | PIH1D1 interactions | EPPK1 MAP4 POLR3H PARK7 HNRNPA1 EFTUD2 UBA1 GSPT2 AHNAK FLNA FLNB SEC31A PDIA3 POLR3A MTHFD1 MTOR ATP1A1 ENO1 | 2.00e-04 | 731 | 190 | 18 | int:PIH1D1 |
| Interaction | HDAC2 interactions | HIF1A ARID4B MAP4 RPN1 PARK7 UBQLN4 GIT2 EFTUD2 BRCA2 AHNAK MKI67 MRE11 FLNA GIT1 POLR3A SMARCA2 SMARCA4 ATP1A1 ENO1 AHNAK2 | 2.03e-04 | 865 | 190 | 20 | int:HDAC2 |
| Interaction | DUX4 interactions | 2.03e-04 | 214 | 190 | 9 | int:DUX4 | |
| Interaction | CLUH interactions | 2.05e-04 | 263 | 190 | 10 | int:CLUH | |
| Interaction | PSMC3 interactions | ZFAND2A HIF1A RPN1 MAPT UBQLN4 PSMD4 PSMD9 EFTUD2 HPF1 MGA ELF2 ATP1A1 LRRFIP2 | 2.07e-04 | 425 | 190 | 13 | int:PSMC3 |
| Cytoband | 17q21.1 | 8.03e-05 | 20 | 194 | 3 | 17q21.1 | |
| GeneFamily | PDZ domain containing | MAGI1 PSMD9 AHNAK LRRC7 SHROOM3 MAGI3 SNTG1 SNTG2 CARD11 AHNAK2 PDZD2 | 1.27e-08 | 152 | 130 | 11 | 1220 |
| GeneFamily | ATPase Na+/K+ transporting subunits | 8.78e-08 | 7 | 130 | 4 | 1208 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 8.37e-04 | 26 | 130 | 3 | 904 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.40e-03 | 8 | 130 | 2 | 939 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.85e-03 | 34 | 130 | 3 | 487 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.22e-03 | 10 | 130 | 2 | 53 | |
| GeneFamily | WD repeat domain containing | 2.89e-03 | 262 | 130 | 7 | 362 | |
| GeneFamily | Proteasome | 3.63e-03 | 43 | 130 | 3 | 690 | |
| GeneFamily | PHD finger proteins | 4.05e-03 | 90 | 130 | 4 | 88 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | EPPK1 MAP4 MAPT UBQLN4 SLC24A3 ADCY1 JAK1 DST OSBPL6 ACSS3 FLNA FLNB MDFIC FARSB MTHFD1 LRRFIP2 AHNAK2 | 4.31e-07 | 534 | 191 | 17 | M12522 |
| Coexpression | WANG_HCP_PROSTATE_CANCER | 1.13e-06 | 106 | 191 | 8 | M17044 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ARID4B SPEF2 SPTAN1 ASH1L PSMB10 GIT2 KMT2E STN1 JAK1 KMT2C DIP2A NFATC3 AHNAK SECISBP2 FLNA MDFIC PLXDC1 RBM33 GNPTAB SH3KBP1 MED1 EPG5 RESF1 SMARCA2 WDR82 CARD11 ENO1 VPS13B | 4.09e-06 | 1492 | 191 | 28 | M40023 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | MAP4 MAPT SPTAN1 PSMB10 HNRNPA1L2 HNRNPA1 ADCY8 AHNAK SPARCL1 ABCC1 SASH1 SMARCA2 ATP1A2 TNXB | 5.20e-06 | 444 | 191 | 14 | MM1051 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | MAP4 MAPT SPTAN1 PSMB10 HNRNPA1L2 ADCY8 AHNAK SPARCL1 ABCC1 SASH1 SMARCA2 ATP1A2 TNXB | 1.45e-05 | 422 | 191 | 13 | M7396 |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 1.50e-05 | 43 | 191 | 5 | M1713 | |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN | 1.71e-05 | 200 | 191 | 9 | M3416 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH1_DN | 1.71e-05 | 200 | 191 | 9 | M5423 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 3.53e-05 | 169 | 191 | 8 | M39230 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | A2M MAP4 HNRNPA1L2 PGD JAK1 AHNAK FLNA COL6A3 MDFIC SASH1 PLXDC1 SH3KBP1 SEC31A NKD1 THY1 ENO1 | 4.24e-05 | 681 | 191 | 16 | M39175 |
| Coexpression | HENDRICKS_SMARCA4_TARGETS_UP | 4.62e-05 | 54 | 191 | 5 | M15057 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 4.62e-05 | 54 | 191 | 5 | MM715 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 5.30e-05 | 179 | 191 | 8 | M39308 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIF1A STK3 DST BRCA2 NFATC3 GLRB PIP5K1A MOK ABCC1 FLNB MDFIC SASH1 MAP3K14 MED1 MTX2 CEP135 SMARCA2 VPS13B | 5.90e-05 | 856 | 191 | 18 | M4500 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | A2M MAGI1 HIF1A MAP4 SPTAN1 PSMB10 SYNPO SUCLG2 EFTUD2 DST AHNAK FGA PLXNB1 FLNA SHROOM3 GNPTAB MAGI3 ITIH5 RESF1 ASS1 ATP1A1 ENO1 NNT | 5.95e-05 | 1276 | 191 | 23 | M39173 |
| Coexpression | GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP | 8.05e-05 | 190 | 191 | 8 | M8190 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 9.88e-05 | 101 | 191 | 6 | M15356 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 1.11e-04 | 199 | 191 | 8 | M9443 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.11e-04 | 199 | 191 | 8 | M5893 | |
| Coexpression | GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP | 1.15e-04 | 200 | 191 | 8 | M8539 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP | 1.15e-04 | 200 | 191 | 8 | M3830 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN | 1.15e-04 | 200 | 191 | 8 | M6020 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 1.15e-04 | 200 | 191 | 8 | M6647 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 1.15e-04 | 200 | 191 | 8 | M5777 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | RPN1 MAPT SPTAN1 KMT2E JAK1 AHNAK FLNA RESF1 SLTM PRKCD UBXN2A | 1.59e-04 | 394 | 191 | 11 | MM3724 |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 1.61e-04 | 70 | 191 | 5 | M40002 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | DHX36 MAP4 ASH1L SLC24A3 GIT2 KMT2E HSPA13 CDCA2 KMT2C GLRB LRRTM4 PIP5K1A MGA SH3KBP1 DIDO1 PDIA3 ITIH5 CLIP3 RESF1 SMARCA2 ATP1A2 EPB41L2 AHNAK2 | 6.20e-07 | 790 | 189 | 23 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | MAP4 ASH1L SLC24A3 GIT2 KMT2E ADCY8 HSPA13 JAK1 KMT2C SPARCL1 MGA PAPPA2 ARSJ SH3KBP1 PDIA3 ITIH5 RESF1 SMARCA2 ATP1A2 TNXB EPB41L2 AHNAK2 | 2.75e-06 | 799 | 189 | 22 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | ARID4B SYNPO KLHL41 BRCA2 GLRB MKI67 ACSS3 TICRR COL6A3 CLIP3 CEP135 SLTM | 1.56e-05 | 298 | 189 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | MAP4 ASH1L SLC24A3 KMT2E ADCY8 JAK1 GSPT2 SPARCL1 MGA PAPPA2 ARSJ SH3KBP1 ITIH5 RESF1 SMARCA2 UNC13C ATP1A2 TNXB EPB41L2 AHNAK2 | 3.05e-05 | 797 | 189 | 20 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.16e-05 | 184 | 189 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MAP4 SPTAN1 KMT2E JAK1 DST AHNAK FLNA COL6A3 ITIH5 SMARCA2 SMARCA4 EPB41L2 | 4.59e-11 | 190 | 193 | 12 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MAP4 SPTAN1 DST CASKIN2 AHNAK ADGRL2 SASH1 GIT1 ITIH5 RESF1 EML1 | 1.30e-09 | 200 | 193 | 11 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.77e-08 | 199 | 193 | 10 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.85e-08 | 200 | 193 | 10 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | MAPT SYT17 SPARCL1 COL6A3 PLXDC1 SH3KBP1 SNTG2 CARD11 EPB41L2 PDZD2 | 1.85e-08 | 200 | 193 | 10 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.85e-08 | 200 | 193 | 10 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.68e-08 | 180 | 193 | 9 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-07 | 192 | 193 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.75e-07 | 193 | 193 | 9 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-07 | 193 | 193 | 9 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-07 | 193 | 193 | 9 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | MAGI1 SLC24A3 STK3 KIAA1328 SHROOM3 MAGI3 AOPEP VPS13B PDZD2 | 2.00e-07 | 196 | 193 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | MAGI1 DCDC1 SYT17 SPEF2 CFAP47 SHROOM3 DNAH10 EPB41L4B ODAD2 | 2.00e-07 | 196 | 193 | 9 | 87d9881cfec461a5d89b688a83749b618c519485 |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.27e-07 | 199 | 193 | 9 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.27e-07 | 199 | 193 | 9 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.27e-07 | 199 | 193 | 9 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.37e-07 | 200 | 193 | 9 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.37e-07 | 200 | 193 | 9 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-07 | 200 | 193 | 9 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.37e-07 | 200 | 193 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.37e-07 | 200 | 193 | 9 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-07 | 200 | 193 | 9 | e0a003d2a5fd6adfcb817c9bc5dceb9c79e7491b | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.74e-07 | 100 | 193 | 7 | 20675fc2ffc5ab63047d38da083b50d470f3db19 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.74e-07 | 100 | 193 | 7 | 1de3895e16f14ff32b901b18ce14d965afaa7e76 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.74e-07 | 100 | 193 | 7 | ff1bdb511700a041a90034d1d30dfc25f51d6c82 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.57e-07 | 162 | 193 | 8 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-06 | 180 | 193 | 8 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | PBMC-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.43e-06 | 81 | 193 | 6 | 6d1e524f000b71c935359afc801a1d31f218fec8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.45e-06 | 184 | 193 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.51e-06 | 185 | 193 | 8 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-06 | 186 | 193 | 8 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.58e-06 | 186 | 193 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.64e-06 | 187 | 193 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 188 | 193 | 8 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.78e-06 | 189 | 193 | 8 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-06 | 132 | 193 | 7 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.92e-06 | 191 | 193 | 8 | ddbc5f97f2aef19be4ad93db4139876c939b848e | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.92e-06 | 191 | 193 | 8 | 2ad717b59215ad8d933e9637d363b65d7298e5d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 192 | 193 | 8 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.00e-06 | 192 | 193 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 192 | 193 | 8 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.08e-06 | 193 | 193 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.08e-06 | 193 | 193 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-06 | 194 | 193 | 8 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.24e-06 | 195 | 193 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.24e-06 | 195 | 193 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.24e-06 | 195 | 193 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-06 | 197 | 193 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.42e-06 | 197 | 193 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 198 | 193 | 8 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.51e-06 | 198 | 193 | 8 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 198 | 193 | 8 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 198 | 193 | 8 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 2.51e-06 | 198 | 193 | 8 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 198 | 193 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-06 | 199 | 193 | 8 | e9009eee7f77b9c9917f8e0e723001d9e76eb553 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 2.61e-06 | 199 | 193 | 8 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 2.61e-06 | 199 | 193 | 8 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.71e-06 | 200 | 193 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-06 | 200 | 193 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.71e-06 | 200 | 193 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 200 | 193 | 8 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.71e-06 | 200 | 193 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.50e-06 | 167 | 193 | 7 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.19e-06 | 169 | 193 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 9.55e-06 | 170 | 193 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 176 | 193 | 7 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 176 | 193 | 7 | cb21342dd135cc80a50aafe7bf8bf31265db68dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 176 | 193 | 7 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 177 | 193 | 7 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 177 | 193 | 7 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-05 | 179 | 193 | 7 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 180 | 193 | 7 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 180 | 193 | 7 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.40e-05 | 120 | 193 | 6 | a6d0406a174d46ce06b41280292931954af88a59 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-05 | 181 | 193 | 7 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-05 | 181 | 193 | 7 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-05 | 181 | 193 | 7 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 1.43e-05 | 181 | 193 | 7 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | tumor_Lung-Fibroblasts-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 1.43e-05 | 181 | 193 | 7 | 53bcab4d6df4a3255d81877ba22fb95d4492ce9f | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.49e-05 | 182 | 193 | 7 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 182 | 193 | 7 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.54e-05 | 183 | 193 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-05 | 183 | 193 | 7 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 184 | 193 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 184 | 193 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 184 | 193 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 185 | 193 | 7 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 185 | 193 | 7 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 185 | 193 | 7 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.71e-05 | 186 | 193 | 7 | fbc4ba4a7a8e5902a1b0add52ece0d6da85a8a5f | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-05 | 187 | 193 | 7 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-05 | 187 | 193 | 7 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.77e-05 | 187 | 193 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-05 | 187 | 193 | 7 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| Drug | Thapsigargin | DHX36 ZFAND2A ARID4B MAP4 RPN1 SYT17 POLR3H SPTAN1 IRF7 PSMD9 HNRNPA1 CDCA2 JAK1 BRCA2 NFATC3 AHNAK MKI67 MCEE ALDH5A1 TICRR COL6A3 SHROOM3 ERO1B DYNC2I2 RBM33 SEC31A PDIA3 POLR3A PRPF3 MTHFD1 SMARCA4 PRKCD | 7.72e-08 | 1353 | 189 | 32 | ctd:D019284 |
| Drug | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | ZFAND2A HIF1A EPPK1 ATP7B PARK7 PSMD4 SYNPO HNRNPA1 MYLK3 ABCC1 FLNC KNSTRN SH3KBP1 THY1 MTHFD1 MTOR PRKCD UNC13C ATP1A1 | 2.24e-07 | 558 | 189 | 19 | ctd:C072553 |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | MAP4 MAPT SLC24A3 ADCY1 NFATC3 PLXNB1 FLNA SASH1 MTOR SMARCA4 EPB41L2 | 8.68e-07 | 198 | 189 | 11 | 4825_DN |
| Drug | A-32686 | 3.10e-06 | 13 | 189 | 4 | CID000004951 | |
| Drug | 22,23-dihydrobufalin | 5.56e-06 | 5 | 189 | 3 | CID000195392 | |
| Drug | thevetin A | 5.56e-06 | 5 | 189 | 3 | CID000441873 | |
| Drug | 3-acetylstrophanthin | 5.56e-06 | 5 | 189 | 3 | CID003082282 | |
| Drug | bromfenacoum | MAP4 SPTAN1 PSMD4 DST AHNAK CASKIN1 MCEE ALDH5A1 PLXNB1 DIDO1 PDIA3 PARS2 HAPLN1 MTX2 MTHFD1 ATP1A3 ENO1 NNT | 7.58e-06 | 644 | 189 | 18 | ctd:C013418 |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 9.99e-06 | 125 | 189 | 8 | CID000002603 | |
| Drug | 2,4-dinitrophenol | 1.02e-05 | 90 | 189 | 7 | CID000001493 | |
| Drug | ETH157 | 1.11e-05 | 6 | 189 | 3 | CID000563154 | |
| Drug | Methamphetamine | MAGI1 ZFAND2A MAP4 MAPT SYT17 SPTAN1 KMT2E STK11IP UBA1 DST NFATC3 SUPT5H AHNAK MKI67 SECISBP2 PIP5K1A FLNA FLNB FLNC KNSTRN CERT1 PDIA3 SIDT2 MTOR PRKCD ATP1A1 ENO1 NNT | 1.40e-05 | 1401 | 189 | 28 | ctd:D008694 |
| Drug | 5'-N-ethylcarboxamidoadenosine | 1.56e-05 | 174 | 189 | 9 | CID000104795 | |
| Drug | 3-MA | 1.62e-05 | 19 | 189 | 4 | CID000447782 | |
| Drug | dihydrodigitoxigenin | 1.92e-05 | 7 | 189 | 3 | CID000107549 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.26e-05 | 191 | 189 | 9 | 4168_DN | |
| Drug | Digoxin | 3.89e-05 | 46 | 189 | 5 | ctd:D004077 | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; HL60; HG-U133A | 4.15e-05 | 197 | 189 | 9 | 1977_UP | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; HL60; HG-U133A | 4.49e-05 | 199 | 189 | 9 | 1782_DN | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.49e-05 | 199 | 189 | 9 | 2302_UP | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 5.16e-08 | 7 | 185 | 4 | DOID:0060178 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 2.42e-07 | 3 | 185 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 2.42e-07 | 3 | 185 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 7.12e-07 | 12 | 185 | 4 | DOID:863 (implicated_via_orthology) | |
| Disease | Liver carcinoma | A2M MAPT PARK7 PGD CDCA2 PNPT1 KMT2C MKI67 TICRR PLXDC1 MED1 PDIA3 THY1 MTOR ENO1 | 8.22e-07 | 507 | 185 | 15 | C2239176 |
| Disease | vital capacity | MAPT KMT2E SUCLG2 ADCY8 STN1 PNPT1 DST CEP120 LRRTM4 OSBPL6 ADGRL2 PAPPA2 COL6A3 SHROOM3 EPB41L4B MAP3K14 ODAD2 MED1 SMARCA2 NNT TNXB EPB41L2 PDZD2 | 3.29e-06 | 1236 | 185 | 23 | EFO_0004312 |
| Disease | epilepsy (implicated_via_orthology) | 9.31e-06 | 163 | 185 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.26e-05 | 48 | 185 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | myeloid white cell count | RPN1 UBQLN4 KMT2E DIP2A SUPT5H PLXNB1 FLNB DNAH10 ATP13A1 MAP3K14 USP8 RTCA GSDMA ATP1A1 ATP1A3 ATP1A4 LY75 ENO1 | 2.72e-05 | 937 | 185 | 18 | EFO_0007988 |
| Disease | Autosomal Dominant Parkinsonism | 2.72e-05 | 28 | 185 | 4 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 2.72e-05 | 28 | 185 | 4 | C0752097 | |
| Disease | Parkinsonism, Experimental | 2.72e-05 | 28 | 185 | 4 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 2.72e-05 | 28 | 185 | 4 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 2.72e-05 | 28 | 185 | 4 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 2.72e-05 | 28 | 185 | 4 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 2.72e-05 | 28 | 185 | 4 | C1868675 | |
| Disease | tauopathy (implicated_via_orthology) | 2.82e-05 | 10 | 185 | 3 | DOID:680 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.39e-05 | 195 | 185 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | Parkinsonism, Juvenile | 3.61e-05 | 30 | 185 | 4 | C0752105 | |
| Disease | Parkinsonian Disorders | 3.61e-05 | 30 | 185 | 4 | C0242422 | |
| Disease | ALTERNATING HEMIPLEGIA OF CHILDHOOD 1 | 3.91e-05 | 2 | 185 | 2 | C3549447 | |
| Disease | arylamine N-acetyltransferase 1 measurement | 3.91e-05 | 2 | 185 | 2 | EFO_0801394 | |
| Disease | sodium channel subunit beta-2 measurement | 3.91e-05 | 2 | 185 | 2 | EFO_0803085 | |
| Disease | alternating hemiplegia of childhood (is_implicated_in) | 3.91e-05 | 2 | 185 | 2 | DOID:0050635 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 4.10e-05 | 100 | 185 | 6 | C0010606 | |
| Disease | urolithiasis | 4.80e-05 | 63 | 185 | 5 | MONDO_0024647 | |
| Disease | neutrophil count | MAGI1 RPN1 MAPT UBQLN4 ASH1L KMT2E DIP2A SUPT5H ADGRL2 PAPPA2 FLNB ATP13A1 MAGI3 RTCA GSDMA UNC13C ATP1A1 ATP1A3 ATP1A4 LY75 ENO1 TNXB | 5.91e-05 | 1382 | 185 | 22 | EFO_0004833 |
| Disease | brain ischemia (implicated_via_orthology) | 6.73e-05 | 35 | 185 | 4 | DOID:2316 (implicated_via_orthology) | |
| Disease | NF-kappa-B essential modulator measurement | 1.17e-04 | 3 | 185 | 2 | EFO_0010597 | |
| Disease | forced expiratory volume | SUCLG2 ADCY8 STN1 PNPT1 DST CEP120 AHNAK OSBPL6 ADGRL2 EEFSEC MED1 EYS SMARCA2 NNT TNXB | 1.45e-04 | 789 | 185 | 15 | EFO_0004314 |
| Disease | Alternating hemiplegia of childhood | 2.33e-04 | 4 | 185 | 2 | C0338488 | |
| Disease | B-cell antigen receptor complex-associated protein alpha chain measurement | 2.33e-04 | 4 | 185 | 2 | EFO_0801402 | |
| Disease | Malignant neoplasm of ovary | 2.33e-04 | 137 | 185 | 6 | C1140680 | |
| Disease | Duchenne muscular dystrophy, disease progression measurement | 2.75e-04 | 50 | 185 | 4 | EFO_0008336, MONDO_0010679 | |
| Disease | Neurodevelopmental Disorders | 3.05e-04 | 93 | 185 | 5 | C1535926 | |
| Disease | cancer (implicated_via_orthology) | 3.05e-04 | 268 | 185 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | abdominal adipose tissue measurement | 3.45e-04 | 53 | 185 | 4 | EFO_0803316 | |
| Disease | interstitial cystitis (is_marker_for) | 3.86e-04 | 5 | 185 | 2 | DOID:13949 (is_marker_for) | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 3.86e-04 | 5 | 185 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | single Ig IL-1-related receptor measurement | 3.86e-04 | 5 | 185 | 2 | EFO_0802072 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 3.86e-04 | 5 | 185 | 2 | C3281201 | |
| Disease | myocardial infarction | 3.88e-04 | 350 | 185 | 9 | EFO_0000612 | |
| Disease | Malignant neoplasm of breast | HIF1A ATP7B SPTAN1 SORCS1 BRCA2 OTOF MKI67 LRRC7 PLXNB1 MRE11 ABCC1 FLNA FLNB EPG5 MTOR ENO1 VPS13B | 4.53e-04 | 1074 | 185 | 17 | C0006142 |
| Disease | breast cancer (implicated_via_orthology) | 5.04e-04 | 25 | 185 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.54e-04 | 447 | 185 | 10 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | ASH1L KMT2E PNPT1 KMT2C ALDH5A1 FARSB CERT1 MTOR ASS1 ATP1A1 | 5.54e-04 | 447 | 185 | 10 | C3714756 |
| Disease | Sezary Syndrome | 6.35e-04 | 27 | 185 | 3 | C0036920 | |
| Disease | bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 measurement | 8.04e-04 | 7 | 185 | 2 | EFO_0802332 | |
| Disease | NAD-dependent protein deacetylase sirtuin-2 measurement | 8.04e-04 | 7 | 185 | 2 | EFO_0008241 | |
| Disease | retinal ischemia (biomarker_via_orthology) | 8.04e-04 | 7 | 185 | 2 | DOID:12510 (biomarker_via_orthology) | |
| Disease | inter-alpha-trypsin inhibitor heavy chain H1 measurement | 8.04e-04 | 7 | 185 | 2 | EFO_0801705 | |
| Disease | osteonecrosis (biomarker_via_orthology) | 8.04e-04 | 7 | 185 | 2 | DOID:10159 (biomarker_via_orthology) | |
| Disease | Ovarian Mucinous Adenocarcinoma | 9.58e-04 | 31 | 185 | 3 | C1335167 | |
| Disease | Hyperkinesia | 1.05e-03 | 32 | 185 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 1.05e-03 | 32 | 185 | 3 | C0751217 | |
| Disease | Ischemic stroke | 1.06e-03 | 324 | 185 | 8 | HP_0002140 | |
| Disease | autoimmune thyroid disease | 1.22e-03 | 126 | 185 | 5 | EFO_0006812 | |
| Disease | peak expiratory flow | 1.25e-03 | 498 | 185 | 10 | EFO_0009718 | |
| Disease | lysophosphatidylethanolamine 18:1 measurement | 1.26e-03 | 34 | 185 | 3 | EFO_0010368 | |
| Disease | melanoma (is_implicated_in) | 1.26e-03 | 34 | 185 | 3 | DOID:1909 (is_implicated_in) | |
| Disease | Hypertensive disease | 1.30e-03 | 190 | 185 | 6 | C0020538 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.37e-03 | 9 | 185 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Carcinoma, Small Cell | 1.37e-03 | 9 | 185 | 2 | C0262584 | |
| Disease | retinal detachment, retinal break | 1.37e-03 | 35 | 185 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | cerebrospinal fluid clusterin measurement | 1.37e-03 | 35 | 185 | 3 | EFO_0007657 | |
| Disease | coronary artery disease | CLTCL1 STN1 STK3 CEP120 LRRC7 ADGRL2 ALDH5A1 COL6A3 SHROOM3 DNAH10 MAGI3 CERT1 EPG5 CEP135 SMARCA4 EML1 TNXB | 1.45e-03 | 1194 | 185 | 17 | EFO_0001645 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.49e-03 | 36 | 185 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | endometrial cancer (is_implicated_in) | 1.49e-03 | 36 | 185 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | serum urea measurement | 1.49e-03 | 195 | 185 | 6 | EFO_0009795 | |
| Disease | ovarian neoplasm | 1.60e-03 | 134 | 185 | 5 | C0919267 | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.70e-03 | 10 | 185 | 2 | GO_0097327, GO_0097328 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.87e-03 | 139 | 185 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | ascending aortic diameter | 1.93e-03 | 140 | 185 | 5 | EFO_0021787 | |
| Disease | cups of coffee per day measurement | 2.02e-03 | 40 | 185 | 3 | EFO_0006782 | |
| Disease | response to anticonvulsant | 2.04e-03 | 85 | 185 | 4 | GO_0036277 | |
| Disease | Jeune thoracic dystrophy | 2.07e-03 | 11 | 185 | 2 | C0265275 | |
| Disease | cortical surface area measurement | MAGI1 DCDC1 MAPT STN1 CEP120 ADGRL2 TICRR FLNB SHROOM3 ERO1B MAP3K14 CERT1 ITIH5 AOPEP ELF2 EML1 TNXB PDZD2 | 2.08e-03 | 1345 | 185 | 18 | EFO_0010736 |
| Disease | Dystonia | 2.13e-03 | 86 | 185 | 4 | C0013421 | |
| Disease | hypothyroidism | 2.18e-03 | 284 | 185 | 7 | EFO_0004705 | |
| Disease | alcohol consumption measurement | MAGI1 MAPT POLR3H PSMD9 SUCLG2 HNRNPA1 ADGRL2 HS3ST2 MGA ACSS3 FARSB MAGI3 MED1 MTOR SNTG2 WDR82 ATP1A3 | 2.18e-03 | 1242 | 185 | 17 | EFO_0007878 |
| Disease | stroke | 2.19e-03 | 144 | 185 | 5 | EFO_0000712 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.25e-03 | 145 | 185 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | renal cell carcinoma | 2.33e-03 | 42 | 185 | 3 | EFO_0000681 | |
| Disease | oral microbiome measurement | 2.33e-03 | 42 | 185 | 3 | EFO_0801229 | |
| Disease | ovarian reserve | 2.48e-03 | 12 | 185 | 2 | EFO_0004770 | |
| Disease | hyperhomocysteinemia (biomarker_via_orthology) | 2.48e-03 | 12 | 185 | 2 | DOID:9279 (biomarker_via_orthology) | |
| Disease | cleft palate (is_implicated_in) | 2.48e-03 | 12 | 185 | 2 | DOID:674 (is_implicated_in) | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 2.48e-03 | 12 | 185 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | eosinophil count | RPN1 MAPT SYT17 SPEF2 HNRNPA1 JAK1 SUPT5H EEFSEC FLNA MAP3K14 SEC31A ACVR1C RESF1 NKD1 SMARCA4 GSDMA CARD11 NNT TNXB | 2.65e-03 | 1488 | 185 | 19 | EFO_0004842 |
| Disease | executive function measurement | 2.68e-03 | 376 | 185 | 8 | EFO_0009332 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 2.84e-03 | 45 | 185 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 2.84e-03 | 45 | 185 | 3 | EFO_0803319 | |
| Disease | osteoarthritis | 2.85e-03 | 222 | 185 | 6 | MONDO_0005178 | |
| Disease | asthma | MAGI1 ARID4B SPEF2 EEFSEC COL6A3 MAP3K14 SEC31A MED1 SMARCA2 GSDMA CARD11 UNC13C | 2.90e-03 | 751 | 185 | 12 | MONDO_0004979 |
| Disease | Coffin-Siris syndrome | 2.91e-03 | 13 | 185 | 2 | C0265338 | |
| Disease | Short Rib-Polydactyly Syndrome | 2.91e-03 | 13 | 185 | 2 | C0036996 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.91e-03 | 13 | 185 | 2 | C1846647 | |
| Disease | smoking status measurement, ulcerative colitis | 2.91e-03 | 13 | 185 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | multiple sclerosis symptom measurement | 3.02e-03 | 46 | 185 | 3 | EFO_0803536 | |
| Disease | response to radiation, hearing loss, response to antineoplastic agent | 3.02e-03 | 46 | 185 | 3 | EFO_0004238, GO_0009314, GO_0097327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ISHGSVVAGVIGAKK | 1091 | P40145 | |
| TNPEHFGTPVIGKKT | 126 | Q4LE39 | |
| KVHPGDNVGTKVETP | 121 | Q9HCE0 | |
| KLGIGIVPGLVHKES | 341 | Q9NR48 | |
| KKPGSTVIAGSINAH | 866 | P35670 | |
| DHGIKEKGVPVSGQE | 361 | Q12774 | |
| GGTKVVQHIPPQKAT | 386 | Q9HD20 | |
| PESKIPVGIKAGHSN | 101 | Q86YB8 | |
| QGSINHKEAVTIPKG | 186 | Q96QA5 | |
| GQGHLSQKKTVTIPS | 196 | P57764 | |
| VGTQGKPAIAHRDIK | 311 | Q8NER5 | |
| DHGIKEKGVPVSGQE | 361 | A5YM69 | |
| PHIKTIFQGIAAKVG | 151 | P52209 | |
| VQGPSLESGDHGKIK | 291 | Q09666 | |
| LAKHTKGPVFAGDVS | 546 | O95490 | |
| KGTTPLHVAAKAGQT | 166 | Q9Y2X7 | |
| KGNTPLHVASKAGQI | 166 | Q14161 | |
| SGASVIKHGLNPEKI | 566 | Q8N6M6 | |
| VPVKVTNVKDGTTHQ | 231 | P00966 | |
| GVPESIEALHKAGIK | 901 | Q9P241 | |
| VVQKKSGGRTEHPFT | 206 | P01023 | |
| VRSPKAQGKSVGVGH | 346 | Q969G9 | |
| QRPGAHLTVKKIFVG | 96 | Q32P51 | |
| GDGPHISSKVRVIKL | 976 | Q96EV2 | |
| TQGPDKVIFLLVGHK | 116 | Q8N4Z0 | |
| AVKSLKPESGGNHIA | 906 | P23458 | |
| KVVTKTFHGAGLVVP | 216 | Q9NWY4 | |
| TSTIGPEGVHQKGVK | 156 | Q8IXS6 | |
| LDPLKATHAVKGVTG | 441 | Q9Y5P4 | |
| SVKHKEAIGPGGEVV | 1046 | Q8WXD9 | |
| SGSKLAVHKPVAIFG | 1056 | M0R2J8 | |
| LGKSKGRTHVQIDPE | 326 | Q9Y278 | |
| ILTPNGTKVAEGHKA | 621 | P58215 | |
| CVAKAVDKVGHVGTP | 3271 | Q86XX4 | |
| GVLVSHEVTKTLGPK | 3931 | Q8NEZ4 | |
| SGHEVKQPGASVKVS | 26 | A0A0B4J1V7 | |
| VDGTPVIGKSHQLVV | 891 | Q96QZ7 | |
| RSKVGSTENIKHQPG | 936 | P27816 | |
| IDGIPVKGKSHKQVL | 776 | Q5TCQ9 | |
| DQGPKQTGIVKHDIL | 1291 | Q5T1H1 | |
| GPKHIQGEKVSDAVE | 341 | Q86VH4 | |
| SEEVKIGAHGKPVIF | 146 | Q96PE7 | |
| QVPSGEEIGKIKNGH | 86 | Q9P1T7 | |
| HTQKTIGGNVTKEKP | 821 | Q3T906 | |
| DGKPTVGETHTLKIL | 406 | Q86UX2 | |
| KAVEVIQLNGPGVHT | 211 | Q8IWI9 | |
| SGKKGHVLFRPTVSQ | 226 | P19827 | |
| GVPVISKGQQKAHVS | 236 | P19823 | |
| EPTKRLGVTGNIKIH | 586 | Q05655 | |
| KSVQNLVGKPSHGVR | 581 | Q96NW7 | |
| SGEKIHLNPVGSDKV | 2491 | Q03001 | |
| RAGKGVIEQTEKSHP | 671 | Q16665 | |
| VGFVHSPLLKNKGTV | 356 | Q5FYB0 | |
| VTGDHPITAKAIAKG | 616 | P05023 | |
| KKHPRGETEVGATAV | 326 | Q96EX3 | |
| ENVGAQKIPGEKSVH | 816 | O43491 | |
| SVIVPSGAPKKEHVN | 191 | Q8IYD1 | |
| SGAPKKEHVNVVFIG | 196 | Q8IYD1 | |
| LGGVDQIHIKPKSKV | 161 | A6NHQ2 | |
| PKVTGLHKVTVLFAG | 321 | O75369 | |
| HIVGSPFKAKVTGQR | 2461 | O75369 | |
| HQVDKGPVDSVTGKA | 1716 | O43157 | |
| EIGFGSKVTTHPLAK | 116 | Q99497 | |
| EEGGKPKHVLSTSGV | 166 | Q32MK0 | |
| RSPHAIVVTQVKEGG | 356 | O15018 | |
| GVEVGKPTHFTVLTK | 881 | Q14315 | |
| QHIVGSPFKAKVTGP | 2581 | Q14315 | |
| AVHKGKIVIAGGVTE | 491 | O60662 | |
| GSVIPAQAHGKIFTK | 1361 | Q8IZD2 | |
| FTIVHGNTGKCIKPV | 36 | O60449 | |
| PGVGKTTLIHKASEV | 11 | Q9BSD7 | |
| AKKNTVNGTGTPVHI | 381 | P48167 | |
| SVIKGKCTVPGHKSI | 191 | Q9Y4A0 | |
| ISKIHDVIGTPAQKI | 211 | Q9UQ07 | |
| KGRTVLQKVVGHPSC | 296 | Q92985 | |
| ITEGKVSGNPQVHIK | 146 | P46013 | |
| PGHTEEAVAAGKTTK | 1356 | P46013 | |
| APLDIQKGKVHGSID | 121 | Q9BZF3 | |
| HKAQVTTKAEVEPGV | 491 | Q99755 | |
| IGVTKPGHRKKIASE | 531 | Q8WXE0 | |
| VHGGGALQPIETLKK | 346 | Q86T90 | |
| DKVGILQHPDGTVLK | 61 | Q8NFU5 | |
| VAIKIPIKHTVENGT | 371 | Q9HC58 | |
| ETVKTGEKHGLVIIP | 516 | Q9Y608 | |
| QPLVSGEHKAQVTTK | 431 | A2A3N6 | |
| QVTTKAEVEPGVHLG | 441 | A2A3N6 | |
| PLTIKLHVDGKVSGV | 1006 | Q9BXP8 | |
| HAVVQTPGGKKRSIA | 151 | Q66GS9 | |
| GVSKAVEHINKTIAP | 61 | P06733 | |
| AAGLPGKVHITKTTL | 431 | Q08828 | |
| DHPITAKAIAKGVGI | 616 | P50993 | |
| VKGRQTPKHISESLG | 171 | P51587 | |
| VKHKILKESVPVGTG | 1486 | P51587 | |
| LKKGSTEINQHPVTV | 291 | Q8N960 | |
| TVDAKHGGKAPLRVQ | 696 | P21333 | |
| GVELGKPTHFTVNAK | 886 | P21333 | |
| TKTDGLVAVHPKSVN | 861 | Q9H2U1 | |
| GVPQVIVVLTDGHSK | 141 | P12111 | |
| GAQAGIKISSVHKRP | 456 | Q9BTC0 | |
| EKGQLTGKHCVSVIP | 276 | O43303 | |
| EKPADGNKTVTHVVV | 556 | Q15723 | |
| CSKTVTKTVIGPDGH | 461 | P02671 | |
| TKTVIGPDGHKEVTK | 466 | P02671 | |
| GPDGHKEVTKEVVTS | 471 | P02671 | |
| ILGTGKIVTPQKHAE | 26 | Q69YH5 | |
| GKHGGNVSLDVLPVK | 2091 | Q8TEP8 | |
| VTGDHPITAKAIAKG | 606 | P13637 | |
| GTGKVKVIPDENGHI | 51 | P48723 | |
| VAGTSKDGKQLPPHV | 291 | O00423 | |
| SGKILPGVKVIIAHT | 1361 | Q14689 | |
| SPGDSVGAKKVHQVT | 491 | Q96DZ5 | |
| KVEGLVVHTNTGKAP | 841 | Q8IVF4 | |
| HTVQPKGKITFCTGI | 76 | P55036 | |
| KEITITNHGKAPGIF | 161 | Q6ZTR5 | |
| GVGKKPSALEHITVE | 2406 | Q6ZTR5 | |
| VQNVSSPHKSEGKGL | 721 | Q9H329 | |
| PVKGDHVIGIVTAKS | 111 | Q9NQT5 | |
| LRKITIGQAPTEKGH | 541 | P11586 | |
| FVHSVKPGSLAEKAG | 691 | Q9BXL7 | |
| VIDKLKHGVVTSGPG | 1306 | Q15648 | |
| HKDVNVVVVEGGPKA | 576 | O43395 | |
| GVQGVLHIPKKDLTD | 551 | Q659C4 | |
| DVAVVGKGDNIKTPH | 376 | Q9HC10 | |
| DPTAFGSGIHKIRIK | 66 | P10915 | |
| KEPIHRVSAAELGGK | 636 | Q99558 | |
| VELGEPAHKKTGTTV | 2461 | P42345 | |
| GPIVQFVKAKGHSLS | 86 | O75431 | |
| HVGKHIFENVIGPKG | 801 | P33527 | |
| LTEQGKKVRFGIHPV | 951 | Q13423 | |
| TPHLTVNNGLKVEKG | 1306 | P0C091 | |
| IGSVVQHSEGKPLNV | 176 | O00233 | |
| QGPLTKTKGIEVGHT | 296 | Q7L3T8 | |
| GGVVTQPLLHKVKSR | 366 | Q8N1F8 | |
| EVKHVGKTDPGTVFV | 66 | Q9NYK5 | |
| VAHGIITEKPGVATK | 81 | Q9C093 | |
| GHPIKQVDVLGTVIG | 51 | Q9H668 | |
| VESHLGVLGPKNVSQ | 16 | Q8NBJ9 | |
| IITAESGKPLKEAHG | 141 | P51649 | |
| KVTHTETGKVLFGPE | 596 | P51531 | |
| GSDPFVKIQLVHGLK | 356 | Q9BSW7 | |
| SIKGGAEHNIPVVVS | 71 | Q9NSN8 | |
| TAVGISKPANIHVKS | 701 | Q9HCM1 | |
| SHLKGQAVPASKTGI | 596 | Q8N3V7 | |
| SHTNKEAIRKAGGIP | 621 | Q5T2S8 | |
| ADGIVSHLKKQAGPA | 121 | P30101 | |
| SVAGVVLLPEGHKKS | 286 | P58107 | |
| PVIKQGAGTTERKHE | 346 | Q96B97 | |
| LHSGGPENDVTKITK | 126 | Q9Y448 | |
| HGQLISVEKVKGDPS | 451 | Q9NWH9 | |
| SKLRVKPGDVAVHGE | 1156 | O14802 | |
| ENVDLKHTGAVLKGP | 246 | P04843 | |
| PVKVIHVESGKILTG | 616 | P51532 | |
| HVESGKILTGTDAPK | 621 | P51532 | |
| SHDPVSGTQGLEKKV | 1641 | Q8TF72 | |
| QHAKQSSKPVVVSVG | 466 | Q96T21 | |
| IGKIKGCSPEGVHVS | 86 | Q9Y535 | |
| KVPHARKTGTTIAGL | 31 | P40306 | |
| LSIKGGSEHNVPVVI | 86 | Q9NY99 | |
| VKDIVKVIDGPHSGR | 596 | O00267 | |
| PTHDALQKTTGKRGI | 1466 | P14410 | |
| EPVIAQKQKHTGAVR | 111 | Q9NQW1 | |
| GAASVIVGHPLDTVK | 16 | Q6ZT89 | |
| VTSLSPGEAVKKHVG | 271 | P49959 | |
| KIKHPTALGLEVGQE | 716 | Q8TCS8 | |
| QSVGKLGVLHPDVIT | 556 | Q9NSD9 | |
| GADIEVKNKAGHTPL | 161 | A7E2S9 | |
| VSEGAGLKGHLPKVQ | 1566 | Q8IVF2 | |
| KVQTGQVDVKLPEGH | 2046 | Q8IVF2 | |
| IDHVKPKVVVTASFG | 211 | Q9H6R3 | |
| HPITAKAIAKGVGII | 626 | Q13733 | |
| TAPHKPTSGIIGVNK | 306 | P53675 | |
| VKKGQIPDVVVGDHI | 66 | Q8N6M9 | |
| KGGVHLTKDPNVVGQ | 101 | Q96I99 | |
| RGPLQTKAKFHITVG | 326 | P57772 | |
| HKESGQVVAIKQVPV | 46 | Q13188 | |
| SKITPQKRHTQAGEG | 1171 | Q7Z2Z1 | |
| GIKVAVLDGKHTGPI | 271 | Q6UXN9 | |
| PGTGDHKVTVKVIAI | 2056 | Q8NB66 | |
| LPVHNKTSGEVLGSK | 1321 | Q6ZQQ2 | |
| HEPAIQGVLDTGKKL | 1816 | Q13813 | |
| IGTTEPGEHQEAKKA | 396 | Q14515 | |
| EITFTPEKIKGGIHT | 76 | O00442 | |
| KESEVTVGGLEPGHK | 1421 | P22105 | |
| KHTGEKPVNAASVGK | 391 | Q9HAH1 | |
| QGHRLGSATPKIVSK | 136 | P68543 | |
| ESPKGAIGHIVSTEK | 2871 | Q6ZS81 | |
| RETKKHVLFGTVGVP | 56 | P04216 | |
| VKASTGGHPVVKLLG | 456 | Q12968 | |
| QEHGVKLGPALTRKV | 1071 | O94885 | |
| KDNIKHVPGGGSVQI | 611 | P10636 | |
| NITHVPGGGNKKIET | 676 | P10636 | |
| PKSGVKIHVSDQELQ | 801 | P22314 | |
| AGVTQTPKFHVLKTG | 21 | A0A0A0MS04 | |
| AGVTQTPKFHILKTG | 21 | A0A0A6YYG3 | |
| SSSPNKKGHVNVIVE | 386 | Q8TCN5 | |
| IKQIATKVHPGGTVN | 2916 | Q7Z7G8 | |
| LGHATSINKPKVEEG | 381 | P0C1S8 | |
| KTKGTPVHLGTIVGI | 416 | Q8IUK5 | |
| VGKVTPLQRVHDGEK | 266 | Q6P280 | |
| VLSGTIHAGQPVKVL | 496 | Q15029 | |
| QRPGAHLTVKKIFVG | 96 | P09651 | |
| KEVVIAQNDKHTGPV | 111 | O94979 | |
| KKSLVEATGVPGQHI | 1006 | Q8WY21 | |
| GIKDGLTVHLVIKTP | 71 | Q9NRR5 | |
| FHSILGPGNIKKAVE | 86 | P40818 | |
| KHKAPVIDIGIANTG | 186 | Q9Y4P3 | |
| VPSIFHLTEKKRGAG | 81 | Q8WY91 | |
| AGVTQTPKFHILKTG | 21 | A0A0J9YX75 |